geoscience.net logo
+ Resolve Article
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter

+ Translate
+ Subscribe to Site Feed
GeoScience Most Shared ContentMost Shared Content

Geography & Life Sciences: Chapter 46962

Chapter 46962 provides bibliographic information on scholary research in geography and in the life sciences.



Perspectives. Changes pressure teaching hospitals. Mcgraw-Hill's Medicine & Health 43(15): Suppl 4 P-Suppl 4 P

Perspectives. Chest pain centers providing relief. Faulkner & Gray's Medicine & Health 46(17): Suppl 4 P.-Suppl 4 P.

Perspectives. Child health gains may hinge on aggressive outreach. Medicine & Health 51(47): Suppl 1-4

Perspectives. Child health: America's next challenge. Mcgraw-Hill's Medicine & Health 41(41): Suppl 4 P.-Suppl 4 P.

Perspectives. Child welfare programs try out managed care model. Faulkner & Gray's Medicine & Health 51(24): Suppl 1-4

Perspectives. Childhood vaccinations: removing the fig leaf. Faulkner & Gray's Medicine & Health 47(7): Suppl 4 P.-Suppl 4 P.

Perspectives. Children's health care: dim prospects for a bright future. Faulkner & Gray's Medicine & Health 48(38): Suppl 1-3

Perspectives. Children's hospitals: gambling on the future. Faulkner & Gray's Medicine & Health 48(16): Suppl 4 P.-Suppl 4 P.

Perspectives. Children, AIDS patients, and the future of the safety net. Faulkner & Gray's Medicine & Health 50(12): Suppl 1-4

Perspectives. Chiropractors: AMA's bone of contention. Faulkner & Gray's Medicine & Health 44(14): Suppl 4 P.-Suppl 4 P.

Perspectives. Chronic care challenges prompt industry partnerships. Faulkner & Gray's Medicine & Health 50(47): Suppl 1-4

Perspectives. Chronic care means altered practice, new institutions. Medicine & Health 56(4): 7-8

Perspectives. Chronic care model: can we get there from here?. Medicine & Health 56(2): 7-8

Perspectives. Chronic disease sufferers: care managers in training?. Medicine & Health 55(41): 7-8

Perspectives. Civil rights for the disabled: a polite revolution. Mcgraw-Hill's Medicine & Health 43(38): Suppl 4 P.-Suppl 4 P.

Perspectives. Clean Air Act: ill wind for hospitals. Faulkner & Gray's Medicine & Health 44(8): Suppl 4 P.-Suppl 4 P.

Perspectives. Cleveland's private sector does its own reforming. Faulkner & Gray's Medicine & Health 49(5): Suppl 1-4

Perspectives. Clinical laboratories feel the heat. Mcgraw-Hill's Medicine & Health 42(32): Suppl 4 P.-Suppl 4 P.

Perspectives. Clinical practice guidelines: winning a dubious audience. Faulkner & Gray's Medicine & Health 49(12): Suppl 1-4

Perspectives. Clinton and Congress: "satisficing" their way to health reform. Faulkner & Gray's Medicine & Health 47(19): Suppl 4 P.-Suppl 4 P.

Perspectives. Clinton cuts a threat to growth of Medicare HMOs?. Faulkner & Gray's Medicine & Health 51(4): Suppl 1-4

Perspectives. Clinton plan offers drug benefit, new outlook on managed care. Medicine & Health 53(27): Suppl 1-4

Perspectives. Clinton unveils Medicare cuts; health groups hold their fire. Faulkner & Gray's Medicine & Health 47(9): Suppl 4 P.-Suppl 4 P.

Perspectives. Coming up short: hospitals seek workers. Mcgraw-Hill's Medicine & Health 43(23): Suppl 4 P.-Suppl 4 P.

Perspectives. Community care pushes ahead. Mcgraw-Hill's Medicine & Health 43(33): Suppl 4 P.-Suppl 4 P.

Perspectives. Competition phase one: HMO vouchers. Washington Report on Medicine & Health 38(25): Suppl 4p-Suppl 4p

Perspectives. Compromise averts repeal of ambitious Kentucky reform. Faulkner & Gray's Medicine & Health 50(16): Suppl 1-4

Perspectives. Congress begins prospective payment experiment. Washington Report on Medicine & Health 37(13): Suppl 4p-Suppl 4p

Perspectives. Congress charts manpower changes. Mcgraw-Hill's Washington Report on Medicine & Health 40(4): Suppl 4 P.-Suppl 4 P.

Perspectives. Congress confronts catastrophic fallout. Mcgraw-Hill's Medicine & Health 43(1): Suppl 4 P.-Suppl 4 P.

Perspectives. Congress ends federal health planning. Mcgraw-Hill's Medicine & Health 40(39): Suppl 4 P.-Suppl 4 P.

Perspectives. Congress eyes capital costs of acquisitions. Washington Report on Medicine & Health 38(15): Suppl 4p-Suppl 4p

Perspectives. Congress finishes reconciliation, veto ahead?. Washington Report on Medicine & Health 39(49): Suppl 6 P.-Suppl 6 P.

Perspectives. Congress in 2000 gets low marks on health, but shows signs of getting serious. Medicine & Health 55(4): Suppl 1-4

Perspectives. Congress looks for transplant solution. Washington Report on Medicine & Health 38(24): Suppl 4p-Suppl 4p

Perspectives. Congress passes Deficit Reduction Act. Washington Report on Medicine & Health 38(27): Suppl 6p-Suppl 6p

Perspectives. Congress produces catastrophic cures. Mcgraw-Hill's Medicine & Health 41(20): Suppl 4 P.-Suppl 4 P.

Perspectives. Congress reconsiders block grants. Washington Report on Medicine & Health 38(26): Suppl 4p-Suppl 4p

Perspectives. Congress tackles disproportionate share. Washington Report on Medicine & Health 39(32): Suppl 4p-Suppl 4p

Perspectives. Congressional outlook 2000: you snooze, you lose. Medicine & Health 54(5): Suppl 1-4

Perspectives. Conquering the last frontier: computerizing patient records. Faulkner & Gray's Medicine & Health 51(6): Suppl 1-4

Perspectives. Consumer's desire for choice threatens cost gains of managed care. Medicine & Health 52(10): Suppl 1-4

Perspectives. Consumers battle Medicaid discrimination. Mcgraw-Hill's Medicine & Health 41(8): Suppl 4 P.-Suppl 4 P.

Perspectives. Consumers gaining leverage in quality assessment arena. Faulkner & Gray's Medicine & Health 50(25): Suppl 1-4

Perspectives. Containing costs by fighting fraud. Faulkner & Gray's Medicine & Health 46(26): Suppl 4 P.-Suppl 4 P.

Perspectives. Coping with drug-exposed infants. Faulkner & Gray's Medicine & Health 44(40): Suppl 4 P.-Suppl 4 P.

Perspectives. Cops or colleagues? Fuzzy standards for judging PROs. Faulkner & Gray's Medicine & Health 50(20): Suppl 1-4

Perspectives. Cornerstone to reform: consumer satisfaction surveys. Faulkner & Gray's Medicine & Health 50(33): Suppl 1-4

Perspectives. Cost containment: the beat goes on. Mcgraw-Hill's Medicine & Health 41(10): Suppl 4 P.-Suppl 4 P.

Perspectives. Cost-cutting alliances bloom across the U.S. Faulkner & Gray's Medicine & Health 48(30): Suppl 1-4

Perspectives. Costs of treating immigrants prompts backlash by states. Faulkner & Gray's Medicine & Health 48(29): Suppl 1-4

Perspectives. Court gives providers new hope. Faulkner & Gray's Medicine & Health 44(27): Suppl 4 P.-Suppl 4 P.

Perspectives. Covering the bases: Clinton & health reform. Faulkner & Gray's Medicine & Health 46(39): Suppl 6 P.-Suppl 6 P.

Perspectives. Crisis in trauma care. Mcgraw-Hill's Medicine & Health 42(34): Suppl 4 P.-Suppl 4 P.

Perspectives. Crisis or crying game? SNFs protest BBA cuts, but others warn that new PPS might still result in overpayment. Medicine & Health 53(19): Suppl 1-4

Perspectives. DC seeks turnaround for fractured health system. Faulkner & Gray's Medicine & Health 50(24): Suppl 1-4

Perspectives. DME demo prompts court challenge, provider anxiety in Sunshine State. Medicine & Health 53(33): Suppl 1-4

Perspectives. DRGs and quality of care. Washington Report on Medicine & Health 39(1): Suppl 4p-Suppl 4p

Perspectives. DRGs boost the emergicenter boom. Washington Report on Medicine & Health 38(13): Suppl 4p-Suppl 4p

Perspectives. DRGs breathe life into PROs. Washington Report on Medicine & Health 37(16): Suppl 4p-Suppl 4p

Perspectives. DRGs change hospital organization, management. Washington Report on Medicine & Health 37(22): 4p-4p

Perspectives. DRGs spur hospital interest in long term care. Washington Report on Medicine & Health 39(4): Suppl 4p-Suppl 4p

Perspectives. DRGs, LOS, and FTEs. Washington Report on Medicine & Health 38(39): Suppl 4p-Suppl 4p

Perspectives. DRGs: some capital ideas. Washington Report on Medicine & Health 37(47): Suppl 4p-Suppl 4p

Perspectives. DRGs: the capital question. Washington Report on Medicine & Health 39(45): Suppl 4 P.-Suppl 4 P.

Perspectives. DSM: a concept coming into focus. Faulkner & Gray's Medicine & Health 50(32): Suppl 1-4

Perspectives. Death with dignity or 'slippery slope' after court rules? Second of two articles. Faulkner & Gray's Medicine & Health 50(42): Suppl 1-4

Perspectives. Debate widens over scope of practice. Washington Report on Medicine & Health 37(28): 4p-4p

Perspectives. Debating the quality of HHS leadership. Faulkner & Gray's Medicine & Health 44(12): Suppl 4 P.-Suppl 4 P.

Perspectives. Debunking small group insurance myths. Faulkner & Gray's Medicine & Health 44(24): Suppl 6 P.-Suppl 6 P.

Perspectives. Democrats: high on health. Part 2. Mcgraw-Hill's Medicine & Health 41(50): Suppl 6 P.-Suppl 6 P.

Perspectives. Dentistry wrestles with change. Faulkner & Gray's Medicine & Health 45(35): Suppl 4 P.-Suppl 4 P.

Perspectives. Denver demonstration tests use of enrollment broker. Faulkner & Gray's Medicine & Health 51(9): Suppl 1-4

Perspectives. Disabilities Act could cost billions. Faulkner & Gray's Medicine & Health 45(37): Suppl 4 P.-Suppl 4 P.

Perspectives. Discharge planning comes of age. Mcgraw-Hill's Medicine & Health 41(6): Suppl 4 P.-Suppl 4 P.

Perspectives. Disease management for Medicare: how many paradigms can we shift today?. Medicine & Health 55(9): Suppl 1-4

Perspectives. Disease management seeks to duck threat of "Balkanization". Faulkner & Gray's Medicine & Health 51(27): Suppl 1-4

Perspectives. Disparities a shadow on US health landscape. Medicine & Health 54(35): Suppl 1-4

Perspectives. Disproportionate share hospitals vs HHS. Washington Report on Medicine & Health 39(15): Suppl 4p-Suppl 4p

Perspectives. Dispute resolution sidesteps court clashes. Faulkner & Gray's Medicine & Health 45(44): Suppl 4 P.-Suppl 4 P.

Perspectives. Do doctors make better network bosses?. Faulkner & Gray's Medicine & Health 48(49): Suppl 1-4

Perspectives. Doctor discipline or doctor bashing?. Mcgraw-Hill's Medicine & Health 42(18): Suppl 4 P.-Suppl 4 P.

Perspectives. Doctor surplus breeds new practice forms. Washington Report on Medicine & Health 37(17): Suppl 4p-Suppl 4p

Perspectives. Doctors and managed care: a rocky road to accommodation. Faulkner & Gray's Medicine & Health 46(46): Suppl 4 P.-Suppl 4 P.

Perspectives. Doctors fight for staff privileges. Washington Report on Medicine & Health 38(23): Suppl 4p-Suppl 4p

Perspectives. Doctors fight mandatory assignment. Mcgraw-Hill's Medicine & Health 40(31): Suppl 4 P.-Suppl 4 P.

Perspectives. Doctors sue to fight economic credentialing. Faulkner & Gray's Medicine & Health 48(39): Suppl 1-4

Perspectives. Doctors' quest for freedom leads back to market angst. Faulkner & Gray's Medicine & Health 49(48): Suppl 1-4

Perspectives. Doctors: how many are too many?. Washington Report on Medicine & Health 38(9): Suppl 4p-Suppl 4p

Perspectives. Does AHCCCS spell access?. Washington Report on Medicine & Health 37(46): Suppl 4p-Suppl 4p

Perspectives. Does AIDS education work?. Mcgraw-Hill's Medicine & Health 42(46): Suppl 4 P.-Suppl 4 P.

Perspectives. Donna Shalala: at year one, angling for center stage. Faulkner & Gray's Medicine & Health 48(5): Suppl 4 P.-Suppl 4 P.

Perspectives. Drop in Medicaid enrollment deflates welfare reform's success story. Medicine & Health 53(32): Suppl 1-4

Perspectives. Drug benefits: a balancing act for Medicare as well as private HMOs. Medicine & Health 53(24): Suppl 1-4

Perspectives. Drug formularies pose legal threat to providers. Faulkner & Gray's Medicine & Health 49(6): Suppl 1-4

Perspectives. Drug testing on the job: seeking a delicate balance. Faulkner & Gray's Medicine & Health 44(5): Suppl 4 P.-Suppl 4 P.

Perspectives. Drug utilization review: apocalypse when?. Faulkner & Gray's Medicine & Health 46(8): Suppl 4 P.-Suppl 4 P.

Perspectives. Dueling managed care bills differ on details. Medicine & Health 55(27): 7-8

Perspectives. Dumping doctor decision raises anxiety. Faulkner & Gray's Medicine & Health 45(29): Suppl 4 P.-Suppl 4 P.

Perspectives. Durenberger targets education costs. Washington Report on Medicine & Health 38(40): Suppl 4p-Suppl 4p

Perspectives. EPSDT regs achieve consensus. Washington Report on Medicine & Health 37(29): 4p-4p

Perspectives. ER backups not one problem, but many. Medicine & Health 56(9): 7-8

Perspectives. ER backups: more room needed but where? And who pays?. Medicine & Health 56(11): 7-8

Perspectives. ER patients: what do they want? Can we make them go away?. Medicine & Health 56(10): 7-8

Perspectives. ERISA sets roadblock for state health reform. Faulkner & Gray's Medicine & Health 46(24): Suppl 4 P.-Suppl 4 P.

Perspectives. ERISA: health reform's first hurdle?. Faulkner & Gray's Medicine & Health 47(2): Suppl 4 P.-Suppl 4 P.

Perspectives. ERs face their own emergency. Medicine & Health 43(43): Suppl 4 P.-Suppl 4 P.

Perspectives. Easing the way toward managed care: point of service. Faulkner & Gray's Medicine & Health 46(30): Suppl 4 P.-Suppl 4 P.

Perspectives. Easy money soon to fade for post-acute providers. Faulkner & Gray's Medicine & Health 50(26): Suppl 1-4

Perspectives. Effectiveness: another name for cost control?. Mcgraw-Hill's Medicine & Health 43(40): Suppl 4 P.-Suppl 4 P.

Perspectives. Effects of PARCA liability measure hard to see behind ERISA's veil. Medicine & Health 52(19): Suppl 1-4

Perspectives. Efficacy studies key to managed behavioral care. Faulkner & Gray's Medicine & Health 50(4): Suppl 1-4

Perspectives. Embers flow through ashes of Washington State's reform. Faulkner & Gray's Medicine & Health 50(14): Suppl 1-4

Perspectives. Employer-sponsored health insurance. Mcgraw-Hill's Medicine & Health 42(33): Suppl 4 P.-Suppl 4 P.

Perspectives. Employers trim offerings, think about coinsurance. Medicine & Health 56(23): 7-8

Perspectives. End game: Congress prepares for health reform vote. Faulkner & Gray's Medicine & Health 48(28): Suppl 1-4

Perspectives. End stage for ESRD regs. Washington Report on Medicine & Health 37(20): Suppl 4p-Suppl 4p

Perspectives. End-of-life movement targets care shortcomings. Faulkner & Gray's Medicine & Health 51(43): Suppl 1-4

Perspectives. Ethics in the hospital nursery. Mcgraw-Hill's Medicine & Health 41(44): Suppl 4 P.-Suppl 4 P.

Perspectives. Even true believers hedge bets on nonprofit deal. Faulkner & Gray's Medicine & Health 49(49): Suppl 1-4

Perspectives. Expanding coverage signals growing demand, acceptance for alternative care. Medicine & Health 52(18): Suppl 1-4

Perspectives. Explaining local variations in private coverage rates: it's the labor market. Medicine & Health 54(9): Suppl 1-4

Perspectives. External appeals touted as consumer confidence builder and liability shield. Medicine & Health 52(22): Suppl 1-4

Perspectives. Extramural GME makes gains one community at a time. Faulkner & Gray's Medicine & Health 51(10): Suppl 1-4

Perspectives. Eyes on the Massachusetts miracle. Faulkner & Gray's Medicine & Health 43(49): Suppl 4 P.-Suppl 4 P.

Perspectives. FDA scandal: white hats, black hats, gray areas. Faulkner & Gray's Medicine & Health 43(48): Suppl 6 P.-Suppl 6 P.

Perspectives. FTC facing an uncertain future. Washington Report on Medicine & Health 37(27): 4p-4p

Perspectives. Facing SCHIP's (State Children's Health Insurance Program) acid test: getting kids care once they're covered. Medicine & Health 52(44): Suppl 1-4

Perspectives. Family planning debate continues. Mcgraw-Hill's Medicine & Health 41(32): Suppl 4 P.-Suppl 4 P.

Perspectives. Family planning remains mired in politics. Faulkner & Gray's Medicine & Health 46(23): Suppl 4 P.-Suppl 4 P.

Perspectives. Family planning: surviving the Reagan agenda. Washington Report on Medicine & Health 37(40): Suppl 4p-Suppl 4p

Perspectives. Fawell bill returns; ERISA questions, HIPAA thicken plot. Faulkner & Gray's Medicine & Health 51(41): Suppl 1-4

Perspectives. Federal benefits revisions: reform or cost control?. Faulkner & Gray's Medicine & Health 44(15): Suppl 4 P.-Suppl 4 P.

Perspectives. Federal dollars boost drive to stop violence against women. Faulkner & Gray's Medicine & Health 50(19): Suppl 1-4

Perspectives. Federal policy and infant health: a debate. Washington Report on Medicine & Health 38(4): Suppl 4p-Suppl 4p

Perspectives. Feds, States look for flexible health reform. Faulkner & Gray's Medicine & Health 47(25): Suppl 4 P.-Suppl 4 P.

Perspectives. Fee schedule threatens payment reform. Faulkner & Gray's Medicine & Health 45(26): Suppl 4 P.-Suppl 4 P.

Perspectives. Fences loom for free-ranging drug prices. Faulkner & Gray's Medicine & Health 45(39): Suppl 4 P-Suppl 4 P

Perspectives. Fetal tissue ban: politicizing science?. Faulkner & Gray's Medicine & Health 44(21): Suppl 2 P.-Suppl 2 P.

Perspectives. Fetal transplants: miracle or threat?. Mcgraw-Hill's Medicine & Health 42(38): Suppl 4 P.-Suppl 4 P.

Perspectives. Few governors warn of health cost crunch; tax cut push continues. Medicine & Health 55(8): Suppl 1-4

Perspectives. Fewer health footsoldiers for the next century?. Faulkner & Gray's Medicine & Health 44(17): Suppl 4 P.-Suppl 4 P.

Perspectives. Finance puts bold, bipartisan imprint on omnibus reform. Faulkner & Gray's Medicine & Health 51(25): Suppl 1-4

Perspectives. Fixing America's vaccine system. Mcgraw-Hill's Medicine & Health 42(43): Suppl 4 P.-Suppl 4 P.

Perspectives. Flap over what HIPAA doesn't do renews concern about individual market problems. Medicine & Health 52(14): Suppl 1-4

Perspectives. Florida builds on managed competition. Faulkner & Gray's Medicine & Health 47(3): Suppl 4 P.-Suppl 4 P.

Perspectives. Florida uproar shakes HMO movement. Mcgraw-Hill's Medicine & Health 41(18): Suppl 4 P.-Suppl 4 P.

Perspectives. Florida: a malpractice microcosm. Mcgraw-Hill's Medicine & Health 41(29): Suppl 4 P.-Suppl 4 P.

Perspectives. Flush economy, impeachment trial color Clinton FY2000 budget. Medicine & Health 53(6): Suppl 1-4

Perspectives. For better or worse, Medicaid shakeout foreshadows aspects of M+C exodus. Medicine & Health 52(45): Suppl 1-4

Perspectives. For once, bipartisan accord: Bush credit is too small. Medicine & Health 56(17): 7-8

Perspectives. Foundations: no longer bit part players. Mcgraw-Hill's Medicine & Health 41(26): Suppl 4 P.-Suppl 4 P.

Perspectives. Four futures: alternative scenarios for health care in the 21st century. Faulkner & Gray's Medicine & Health 50(3): Suppl 1-4

Perspectives. Frayed connections: can funding health centers save the safety net?. Medicine & Health 54(34): Suppl 1-4

Perspectives. Free clinics: hippie holdover or wave of the future?. Faulkner & Gray's Medicine & Health 45(43): Suppl 4 P.-Suppl 4 P.

Perspectives. Freedom and responsibility hard to balance in Medicaid. Faulkner & Gray's Medicine & Health 49(27): Suppl 1-4

Perspectives. From competition to DRGs: 1982 in review. Washington Report on Medicine & Health 37(2): Suppl 6p-Suppl 6p

Perspectives. Fungibility factor looms large in DSH, child health decisions. Faulkner & Gray's Medicine & Health 51(30): Suppl 1-4

Perspectives. Future retirees may get little employer help for health. Medicine & Health 55(33): 7-8

Perspectives. GAO keeps prodding, but HCFA treats sensitive disenrollment data cautiously. Medicine & Health 52(21): Suppl 1-4

Perspectives. GME payments under fire. Washington Report on Medicine & Health 39(24): Suppl 4p-Suppl 4p

Perspectives. GOP sets its sights on Food and Drug Administration. Faulkner & Gray's Medicine & Health 49(8): Suppl 1-4

Perspectives. Genetic discrimination issues emerges on uncertain terms. Faulkner & Gray's Medicine & Health 50(21): Suppl 1-4

Perspectives. Geographic reclassification triggers dissension. Faulkner & Gray's Medicine & Health 45(34): Suppl 4 P.-Suppl 4 P.

Perspectives. Geography is destiny in atlas of care variations. Faulkner & Gray's Medicine & Health 50(6): Suppl 1-4

Perspectives. Getting into compliance--avoiding the treacherous terrain of fraud and abuse. Medicine & Health 52(47): Suppl 1-4

Perspectives. Global budgets: defined by the details. Faulkner & Gray's Medicine & Health 47(32): Suppl 4 P.-Suppl 4 P.

Perspectives. Global budgets: medicine with side effects. Faulkner & Gray's Medicine & Health 46(38): Suppl 4 P.-Suppl 4 P.

Perspectives. Good-bye, Hawaii: changes ahead in corporate-backed CME. Faulkner & Gray's Medicine & Health 47(29): Suppl 4 P.-Suppl 4 P.

Perspectives. Gore: more funds for Medicare, incremental steps for access. Medicine & Health 54(27): Suppl 1-4

Perspectives. Government as purchaser: making policy by contract. Faulkner & Gray's Medicine & Health 50(40): Suppl 1-4

Perspectives. Gramm-Rudman: the party's over. Washington Report on Medicine & Health 39(48): Suppl 4p-Suppl 4p

Perspectives. Grassroots state initiatives wage war on cancer pain. Faulkner & Gray's Medicine & Health 49(32): Suppl 1-4

Perspectives. Growing reliance on self-reported HEDIS data underscores need for auditing. Medicine & Health 52(20): Suppl 1-4

Perspectives. HCFA coverage rule: prudent purchasing or bureaucracy run amok?. Medicine & Health 54(23): Suppl 1-4

Perspectives. HCFA holds ground on physician incentive plans. Faulkner & Gray's Medicine & Health 50(37): Suppl 1-4

Perspectives. HCFA retooling to keep pace with booming Medicare HMO. Faulkner & Gray's Medicine & Health 50(13): Suppl 1-4

Perspectives. HCFA says kin can kick in. Washington Report on Medicine & Health 37(19): Suppl 4p-Suppl 4p

Perspectives. HCFA takes heat on lab regulations. Faulkner & Gray's Medicine & Health 45(20): Suppl 4 P.-Suppl 4 P.

Perspectives. HCFA's mortality data: what do they say about quality?. Faulkner & Gray's Medicine & Health 48(42): Suppl 1-4

Perspectives. HCFA: where it's been, where it's going. Faulkner & Gray's Medicine & Health 46(31): Suppl 6 P.-Suppl 6 P.

Perspectives. HHS launches employer-sponsored health plans. Mcgraw-Hill's Medicine & Health 41(48): Suppl 4 P.-Suppl 4 P.

Perspectives. HHS targets home health costs. Washington Report on Medicine & Health 39(31): Suppl 4p-Suppl 4p

Perspectives. HHS's new big cheese: compassionate conservative who wielded the imperial veto. Medicine & Health 55(5): Suppl 1-4

Perspectives. HHS, Republicans both defer to managed care industry. Faulkner & Gray's Medicine & Health 49(38): Suppl 1-4

Perspectives. HIPAA boosts state reform, but glitches raise concern. Faulkner & Gray's Medicine & Health 51(39): Suppl 1-4

Perspectives. HIV survival gains peak; but high prevalence among disadvantaged means new chronic care challenge. Medicine & Health 52(42): Suppl 1-4

Perspectives. HMO future: national or regional?. Mcgraw-Hill's Medicine & Health 43(9): Suppl 4 P.-Suppl 4 P.

Perspectives. HMO inquiry imperils Medicare voucher plan. Mcgraw-Hill's Washington Report on Medicine & Health 40(20): Suppl 4 P.-Suppl 4 P.

Perspectives. HMOs grow and change. Washington Report on Medicine & Health 39(26): Suppl 4p-Suppl 4p

Perspectives. HMOs sustain a backlash from providers and lawmakers. Faulkner & Gray's Medicine & Health 48(35): Suppl 1-4

Perspectives. HMOs' legislative odyssey, Medicare changes, science explosion are top stories of 1998--and likely to dominate news again next year. Medicine & Health 52(50): Suppl 1-4

Perspectives. HMOs: at the crossroads. Mcgraw-Hill's Medicine & Health 42(17): Suppl 4 P.-Suppl 4 P.

Perspectives. Harvard's new theory of relativity. Mcgraw-Hill's Medicine & Health 42(40): Suppl 4 P.-Suppl 4 P.

Perspectives. Has hospital deregulation failed?. Washington Report on Medicine & Health 37(5): Suppl 4p-Suppl 4p

Perspectives. Haste makes waste in states' managed behavioral care efforts. Medicine & Health 52(26): Suppl 1-4

Perspectives. Hawaii: universal care in paradise. Faulkner & Gray's Medicine & Health 46(21): Suppl 4 P.-Suppl 4 P.

Perspectives. Health and the Internet: market share battle starts heating up. Medicine & Health 54(2): Suppl 1-4

Perspectives. Health benefits: employers in the driver's seat. Washington Report on Medicine & Health 39(27): Suppl 4p-Suppl 4p

Perspectives. Health care costs soar toward $1 trillion. Faulkner & Gray's Medicine & Health 47(4): Suppl 4 P.-Suppl 4 P.

Perspectives. Health care fraud & abuse: changing to fit the times. Faulkner & Gray's Medicine & Health 49(13): Suppl 1-4

Perspectives. Health care goes to school. Faulkner & Gray's Medicine & Health 46(1): Suppl 4 P.-Suppl 4 P.

Perspectives. Health care in the 21st century: slow focus shift to chronic ills. Medicine & Health 55(36): 7-8

Perspectives. Health care outsiders get into the act. Washington Report on Medicine & Health 39(39): Suppl 4 P.-Suppl 4 P.

Perspectives. Health care reform: Soviet style. Faulkner & Gray's Medicine & Health 44(39): Suppl 6 P.-Suppl 6 P.

Perspectives. Health care reform: it won't come easy. Faulkner & Gray's Medicine & Health 45(9): Suppl 4 P.-Suppl 4 P.

Perspectives. Health care reform: state's-eye view. Faulkner & Gray's Medicine & Health 44(34): Suppl 4 P.-Suppl 4 P.

Perspectives. Health care spending to hit new high: $1 trillion. Faulkner & Gray's Medicine & Health 48(2): Suppl 4 P.-Suppl 4 P.

Perspectives. Health care spending: growing through the year 2000. Mcgraw-Hill's Medicine & Health 41(25): Suppl 4 P.-Suppl 4 P.

Perspectives. Health care unions on the move. Mcgraw-Hill's Washington Report on Medicine & Health 40(9): Suppl 4 P.-Suppl 4 P.

Perspectives. Health costs: shifting or sharing?. Washington Report on Medicine & Health 37(31): 4p-4p

Perspectives. Health gains of seniors may offset some new Medicare technology costs. Medicine & Health 53(9): Suppl 1-4

Perspectives. Health industry wields computers in cost, quality battle. Faulkner & Gray's Medicine & Health 47(12): Suppl 4 P.-Suppl 4 P.

Perspectives. Health insurance tax break: sacred cow on chopping block?. Faulkner & Gray's Medicine & Health 50(15): Suppl 1-4

Perspectives. Health insurance: prospects in the 1990s. Faulkner & Gray's Medicine & Health 44(22): Suppl 4 P.-Suppl 4 P.

Perspectives. Health law round-up. Mcgraw-Hill's Medicine & Health 40(43): Suppl 4 P.-Suppl 4 P.

Perspectives. Health person of the year. Medicine & Health 56(1): 7-8

Perspectives. Health planning faces new challenges. Mcgraw-Hill's Washington Report on Medicine & Health 40(7): Suppl 4 P.-Suppl 4 P.

Perspectives. Health planning looks to the future. Washington Report on Medicine & Health 37(48): Suppl 4p-Suppl 4p

Perspectives. Health planning uncertainty continues. Washington Report on Medicine & Health 37(21): Suppl 4p-Suppl 4p

Perspectives. Health plans, teaching centers seek strategic alliances. Faulkner & Gray's Medicine & Health 49(36): Suppl 1-4

Perspectives. Health policy and the homeless. Mcgraw-Hill's Medicine & Health 42(10): Suppl 4 P.-Suppl 4 P.

Perspectives. Health reform and the poor: empty promises or a promising blueprint?. Faulkner & Gray's Medicine & Health 47(47): Suppl 4 P.-Suppl 4 P.

Perspectives. Health workers worry about AIDS risk. Mcgraw-Hill's Medicine & Health 41(24): Suppl 4 P.-Suppl 4 P.

Perspectives. Healthy People 2010: brave new objectives aim high, but what is feasible?. Medicine & Health 53(5): Suppl 1-4

Perspectives. Heirs to White House quality panel soldier on in quest to create measurement forum. Medicine & Health 52(49): Suppl 1-4

Perspectives. Help wanted: nurses, nurses, nurses. Mcgraw-Hill's Medicine & Health 42(25): Suppl 4 P.-Suppl 4 P.

Perspectives. High court tackles right-to-die. Mcgraw-Hill's Medicine & Health 43(31): Suppl 4 P.-Suppl 4 P.

Perspectives. High stakes bidding on capital. Faulkner & Gray's Medicine & Health 44(49): Suppl 4 P.-Suppl 4 P.

Perspectives. High-tech, primary care-oriented, Finland tackles care quality, choice. Medicine & Health 54(31): Suppl 1-4

Perspectives. History lesson: "privatization" nothing new for Medicare. Faulkner & Gray's Medicine & Health 49(31): Suppl 1-4

Perspectives. Hitting the FDA ... again. Faulkner & Gray's Medicine & Health 44(41): Suppl 4 P.-Suppl 4 P.

Perspectives. Hodgepodge of Medicare cost-sharing staggers beneficiaries. Faulkner & Gray's Medicine & Health 51(8): Suppl 1-4

Perspectives. Holes in the safety net: Medicare and vulnerable populations. Faulkner & Gray's Medicine & Health 48(47): Suppl 1-4

Perspectives. Home health PPS spells relief to some, but fate of sickest uncertain. Medicine & Health 54(30): Suppl 1-4

Perspectives. Home health care: cost-benefit dilemma. Washington Report on Medicine & Health 37(36): 4p-4p

Perspectives. Home health care: what price security?. Faulkner & Gray's Medicine & Health 48(12): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospice struggles into second year. Washington Report on Medicine & Health 38(41): Suppl 4p-Suppl 4p

Perspectives. Hospital advertising and marketing. Washington Report on Medicine & Health 39(23): Suppl 4p-Suppl 4p

Perspectives. Hospital challenges continue. Mcgraw-Hill's Medicine & Health 41(5): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospital continuing care arrangements. Washington Report on Medicine & Health 39(19): Suppl 4p-Suppl 4p

Perspectives. Hospital costs contribute to double-digit 2003 premium hikes. Medicine & Health 56(22): 7-8

Perspectives. Hospital death rates: the 1987 release. Mcgraw-Hill's Medicine & Health 42(1): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospital linkages: horizontal integration. Washington Report on Medicine & Health 38(5): Suppl 4p-Suppl 4p

Perspectives. Hospital unity: the impossible dream?. Faulkner & Gray's Medicine & Health 44(44): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospital wars: is peace in sight?. Faulkner & Gray's Medicine & Health 46(41): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospital/physician relationships. Washington Report on Medicine & Health 39(17): Suppl 4p-Suppl 4p

Perspectives. Hospitals cater to women's market. Mcgraw-Hill's Medicine & Health 41(33): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospitals fight the tax man. Mcgraw-Hill's Medicine & Health 42(21): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospitals fill beds with nursing care patients. Mcgraw-Hill's Washington Report on Medicine & Health 40(23): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospitals prepare to swallow capital reform. Faulkner & Gray's Medicine & Health 45(21): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospitals urge damage control on capital payments. Mcgraw-Hill's Washington Report on Medicine & Health 40(12): Suppl 4 P.-Suppl 4 P.

Perspectives. Hospitals: a proprietary interest. Washington Report on Medicine & Health 37(23): 4p-4p

Perspectives. House Medicare Rx bill: doing what it takes for choice?. Medicine & Health 54(29): Suppl 1-4

Perspectives. House and Senate diverge on DRGs. Washington Report on Medicine & Health 37(12): Suppl 4p-Suppl 4p

Perspectives. House subcommittee vote signals AHCPR reprieve. Faulkner & Gray's Medicine & Health 49(29): Suppl 1-4

Perspectives. House-Senate budget comparison. Washington Report on Medicine & Health 39(37): Suppl 6 P.-Suppl 6 P.

Perspectives. How healthy is American medical education?. Faulkner & Gray's Medicine & Health 44(48): Suppl 4 P.-Suppl 4 P.

Perspectives. Hybrids take center stage as new phase in cost war looms. Faulkner & Gray's Medicine & Health 51(14): Suppl 1-4

Perspectives. IRS assaults flexible benefits. Washington Report on Medicine & Health 38(21): Suppl 4p-Suppl 4p

Perspectives. Idealistic hospice industry confronts managed care era. Faulkner & Gray's Medicine & Health 49(18): Suppl 1-4

Perspectives. Ides of March a wary time for inner city hospitals. Faulkner & Gray's Medicine & Health 50(11): Suppl 1-4

Perspectives. Immigration law opens golden doors--for some. Faulkner & Gray's Medicine & Health 45(30): Suppl 4 P.-Suppl 4 P.

Perspectives. In search of a malpractice cure. Faulkner & Gray's Medicine & Health 47(23): Suppl 4 P.-Suppl 4 P.

Perspectives. Incrementalism for the uninsured: kids health top '97 story. Medicine & Health 52(1): Suppl 1-4

Perspectives. Indefinite results in ABMT (autologous bone marrow transplantation) trials add to challenges for practice standards, quality assurance in cancer care. Medicine & Health 53(16): Suppl 1-4

Perspectives. Individual market: endangered habitat for indemnity insurance. Faulkner & Gray's Medicine & Health 50(7): Suppl 1-4

Perspectives. Information privacy: front burner issue in '98 session?. Medicine & Health 51(44): Suppl 1-4

Perspectives. Informed consumer choice still a distant and difficult goal. Faulkner & Gray's Medicine & Health 51(35): Suppl 1-4

Perspectives. Inner cities view reform with hope and doubt. Faulkner & Gray's Medicine & Health 47(24): Suppl 4 P.-Suppl 4 P.

Perspectives. Insurance agents: they won the battle, but the war goes on. Faulkner & Gray's Medicine & Health 48(40): Suppl 1-4

Perspectives. Insurance market reform: too little or just enough?. Faulkner & Gray's Medicine & Health 48(26): Suppl 1-4

Perspectives. Insurance reform sleeper: Medicare contracting overhaul. Faulkner & Gray's Medicine & Health 50(48): Suppl 1-4

Perspectives. Integration, conversion mark HMO growth. Washington Report on Medicine & Health 38(17): Suppl 4p-Suppl 4p

Perspectives. Internet likely to open brave new world in global pharmaceuticals trade. Medicine & Health 54(39): Suppl 1-4

Perspectives. Intervention and treatment of elderly alcoholics and problem drinkers. Interview by Millree Williams. Alcohol Health and Research World 8(3): 48-52

Perspectives. Into the fray: states take the lead on health reform. Faulkner & Gray's Medicine & Health 45(36): Suppl 4 P.-Suppl 4 P.

Perspectives. Is American health care ripe for reform?. Faulkner & Gray's Medicine & Health 44(4): Suppl 6 P.-Suppl 6 P.

Perspectives. Is DRG creep spoiling the system?. Washington Report on Medicine & Health 38(35): Suppl 4p-Suppl 4p

Perspectives. Is Medicare plan flawed by exclusion of partial risk?. Faulkner & Gray's Medicine & Health 51(23): Suppl 1-4

Perspectives. Is health reform the answer to the deficit?. Faulkner & Gray's Medicine & Health 46(27): Suppl 4 P.-Suppl 4 P.

Perspectives. Is the evidence movement on track? International group urges new strategies. Medicine & Health 53(49): Suppl 1-4

Perspectives. Is there a doctor in-house?. Faulkner & Gray's Medicine & Health 46(37): Suppl 4 P.-Suppl 4 P.

Perspectives. It's lonely in the middle of the road: big story is compromises not agreed to. Medicine & Health 55(1): Suppl 1-4

Perspectives. Jewish hospitals: staying when the getting gets tough. Faulkner & Gray's Medicine & Health 46(36): Suppl 4 P.-Suppl 4 P.

Perspectives. Joint venture interest grows. Washington Report on Medicine & Health 39(44): Suppl 4 P.-Suppl 4 P.

Perspectives. Joint ventures: mixing medicine and profits. Faulkner & Gray's Medicine & Health 44(38): Suppl 4 P.-Suppl 4 P.

Perspectives. Justice ruling on Aetna-Pru raises bar for future deals. Medicine & Health 53(36): Suppl 1-4

Perspectives. Kassebaum tackles alliances, ERISA, and individual market. Faulkner & Gray's Medicine & Health 49(30): Suppl 1-4

Perspectives. Keeping an eye on the pie. Faulkner & Gray's Medicine & Health 44(33): Suppl 4 P.-Suppl 4 P.

Perspectives. Kids' coverage crisis: next target for 'consensus' reform?. Faulkner & Gray's Medicine & Health 50(30): Suppl 1-4

Perspectives. Kids' deal must seek to build on workplace coverage. Faulkner & Gray's Medicine & Health 51(19): Suppl 1-4

Perspectives. Latest in make-overs: rural hospitals. Mcgraw-Hill's Medicine & Health 43(25): Suppl 4 P.-Suppl 4 P.

Perspectives. Lawmakers block that kickback. Mcgraw-Hill's Medicine & Health 43(13): Suppl 4 P.-Suppl 4 P.

Perspectives. Legislators prescribe malpractice reforms. Washington Report on Medicine & Health 38(18): Suppl 4p-Suppl 4p

Perspectives. Legislators push PPOs. Washington Report on Medicine & Health 38(16): Suppl 4p-Suppl 4p

Perspectives. Lessons from abroad in long term care. Faulkner & Gray's Medicine & Health 47(41): Suppl 4 P.-Suppl 4 P.

Perspectives. Liability lawsuits: casting a wider net. Faulkner & Gray's Medicine & Health 46(18): Suppl 4 P.-Suppl 4 P.

Perspectives. Liability limits loom likely. Mcgraw-Hill's Washington Report on Medicine & Health 40(13): Suppl 4 P.-Suppl 4 P.

Perspectives. Life and death after Cruzan. Faulkner & Gray's Medicine & Health 45(2): Suppl 4 P.-Suppl 4 P.

Perspectives. Life and death decisions. Mcgraw-Hill's Medicine & Health 43(7): Suppl 4 P.-Suppl 4 P.

Perspectives. Life and death decisions in the nursery. Mcgraw-Hill's Washington Report on Medicine & Health 40(26): Suppl 4 P.-Suppl 4 P.

Perspectives. Limited victory in the war on cancer. Faulkner & Gray's Medicine & Health 46(3): Suppl 4 P.-Suppl 4 P.

Perspectives. Limited-service rural hospital program going national after years of incubation, but seed-money appropriation is stalled. Medicine & Health 52(31): Suppl 1-4

Perspectives. Little bang for buck in coverage credits for firms. Medicine & Health 55(14): Suppl 1-2

Perspectives. Living will concept boosted by Cruzan ruling. Faulkner & Gray's Medicine & Health 44(28): Suppl 4 P.-Suppl 4 P.

Perspectives. Lobbyists gird for the health care revolution. Faulkner & Gray's Medicine & Health 47(5): Suppl 6 P.-Suppl 6 P.

Perspectives. Long road ahead to integration of primary and behavioral care. Faulkner & Gray's Medicine & Health 51(16): Suppl 1-4

Perspectives. Long term care alternatives. Washington Report on Medicine & Health 38(11): Suppl 4p-Suppl 4p

Perspectives. Long term care insurance. Washington Report on Medicine & Health 39(16): Suppl 4p-Suppl 4p

Perspectives. Long term care looks for long term gains. Faulkner & Gray's Medicine & Health 45(8): Suppl 4 P.-Suppl 4 P.

Perspectives. Look homeward, health care. Faulkner & Gray's Medicine & Health 46(48): Suppl 4 P.-Suppl 4 P.

Perspectives. M+C heads back to the drawing board. Medicine & Health 55(44): 7-8

Perspectives. MBHOs (managed behavioral healthcare organizations) advancing gradually with implementation of guidelines. Medicine & Health 53(42): Suppl 1-4

Perspectives. MN business group fosters new wave of competition. Faulkner & Gray's Medicine & Health 49(14): Suppl 1-4

Perspectives. Making more organ transplants available. Washington Report on Medicine & Health 39(36): Suppl 4p-Suppl 4p

Perspectives. Making up for lost time: the new AIDS czar. Faulkner & Gray's Medicine & Health 47(27): Suppl 4 P.-Suppl 4 P.

Perspectives. Malpractice crisis brews in West Virginia. Mcgraw-Hill's Washington Report on Medicine & Health 40(21): Suppl 4 P.-Suppl 4 P.

Perspectives. Malpractice insurance: affordability crisis?. Washington Report on Medicine & Health 38(48): Suppl 4p-Suppl 4p

Perspectives. Malpractice insurance: the market gets tighter. Mcgraw-Hill's Washington Report on Medicine & Health 40(5): Suppl 4 P.-Suppl 4 P.

Perspectives. Malpractice: calm before the storm?. Mcgraw-Hill's Medicine & Health 43(37): Suppl 4 P.-Suppl 4 P.

Perspectives. Managed care agnostics question savings claims. Faulkner & Gray's Medicine & Health 49(34): Suppl 1-4

Perspectives. Managed care brings danger and opportunity for research. Faulkner & Gray's Medicine & Health 51(18): Suppl 1-4

Perspectives. Managed care consumers' law requires renegotiating ERISA. Faulkner & Gray's Medicine & Health 51(42): Suppl 1-4

Perspectives. Managed care for disabled: big hole in Medicaid plan. Faulkner & Gray's Medicine & Health 49(43): Suppl 1-4

Perspectives. Managed care forces new attempts to answer old questions about relationship between public health and medical care. Medicine & Health 52(46): Suppl 1-4

Perspectives. Managed care, capitation slowly take root in home care industry. Faulkner & Gray's Medicine & Health 51(11): Suppl 1-4

Perspectives. Managed competition in rural areas: will the seed take?. Faulkner & Gray's Medicine & Health 47(11): Suppl 4 P.-Suppl 4 P.

Perspectives. Managed competition vies for first place. Faulkner & Gray's Medicine & Health 46(28): Suppl 4 P.-Suppl 4 P.

Perspectives. Managed competition: antitrust-buster?. Faulkner & Gray's Medicine & Health 47(14): Suppl 4 P.-Suppl 4 P.

Perspectives. Managed health care comes of age. Faulkner & Gray's Medicine & Health 47(49): Suppl 4 P.-Suppl 4 P.

Perspectives. Managing risk continues to confound policymakers. Faulkner & Gray's Medicine & Health 48(41): Suppl 1-4

Perspectives. Mandatory assignment sweeps northeast. Mcgraw-Hill's Medicine & Health 42(31): Suppl 4 P.-Suppl 4 P.

Perspectives. Many agendas converging on President's Commission. Faulkner & Gray's Medicine & Health 50(36): Suppl 1-4

Perspectives. Mapping boundaries between specialist and primary care. Faulkner & Gray's Medicine & Health 49(37): Suppl 1-4

Perspectives. Market forces cutting costs; long term effects unknown. Faulkner & Gray's Medicine & Health 49(16): Suppl 1-4

Perspectives. Maryland reform seeks cost containment. Faulkner & Gray's Medicine & Health 47(26): Suppl 4 P.-Suppl 4 P.

Perspectives. MedPAC rethinks GME: conceptual high ground atop a slippery slope. Medicine & Health 53(35): Suppl 1-4

Perspectives. MedPAC: cost-sharing changes could boost Medicare efficiency. Medicine & Health 56(24): 7-8

Perspectives. Medicaid HMOs: endangered species. Mcgraw-Hill's Medicine & Health 43(18): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid HMOs: going gets tougher in new environment. Medicine & Health 52(2): Suppl 1-4

Perspectives. Medicaid at 25: rising expectations. Faulkner & Gray's Medicine & Health 44(32): Suppl 8 P.-Suppl 8 P.

Perspectives. Medicaid at 30 years: on the brink of revolution. Faulkner & Gray's Medicine & Health 49(9): Suppl 1-4

Perspectives. Medicaid case management: a rare bright spot. Faulkner & Gray's Medicine & Health 45(38): Suppl 4 P-Suppl 4 P

Perspectives. Medicaid donations: scam or savior?. Faulkner & Gray's Medicine & Health 45(28): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid growth continues at slow pace. Washington Report on Medicine & Health 39(40): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid is vital ... and hostage to demography, economic trends. Medicine & Health 56(20): 7-8

Perspectives. Medicaid managed care in NY: a tidal wave of competition. Faulkner & Gray's Medicine & Health 48(43): Suppl 1-4

Perspectives. Medicaid managed care still evolving; costs could grow. Faulkner & Gray's Medicine & Health 51(7): Suppl 1-4

Perspectives. Medicaid managed care: is a national standard for quality reasonable?. Medicine & Health 51(45): Suppl 1-4

Perspectives. Medicaid managed care: is it time?. Faulkner & Gray's Medicine & Health 46(15): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid oversight failures cloud block grant scenario. Faulkner & Gray's Medicine & Health 49(28): Suppl 1-4

Perspectives. Medicaid physician payment reform: the next horizon. Faulkner & Gray's Medicine & Health 45(15): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid population challenges managed behavioral care. Faulkner & Gray's Medicine & Health 50(39): Suppl 1-4

Perspectives. Medicaid rules force couples to bankruptcy. Mcgraw-Hill's Medicine & Health 41(12): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid spending slows down. Washington Report on Medicine & Health 39(20): Suppl 4p-Suppl 4p

Perspectives. Medicaid under the microscope. Faulkner & Gray's Medicine & Health 45(27): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid waivers pave a pathway for reform. Faulkner & Gray's Medicine & Health 47(37): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid: a 1986 report card. Mcgraw-Hill's Medicine & Health 41(22): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid: end it or mend it?. Faulkner & Gray's Medicine & Health 46(49): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid: moving too fast?. Mcgraw-Hill's Medicine & Health 43(35): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid: to cap or not to cap. Washington Report on Medicine & Health 39(11): Suppl 4p-Suppl 4p

Perspectives. Medicaid: today and tomorrow. Part 1. Mcgraw-Hill's Medicine & Health 42(11): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicaid: tomorrow and beyond. Part 2. Mcgraw-Hill's Medicine & Health 42(12): Suppl 4 P.-Suppl 4 P.

Perspectives. Medical education: reforms on horizon. Mcgraw-Hill's Medicine & Health 41(31): Suppl 4 P.-Suppl 4 P.

Perspectives. Medical education: the slow pace of reform. Faulkner & Gray's Medicine & Health 46(16): Suppl 4 P.-Suppl 4 P.

Perspectives. Medical effectiveness initiatives. Mcgraw-Hill's Medicine & Health 43(20): Suppl 4 P.-Suppl 4 P.

Perspectives. Medical research: coping in a new era. Faulkner & Gray's Medicine & Health 45(10): Suppl 4 P.-Suppl 4 P.

Perspectives. Medical technology faces uncertain future. Mcgraw-Hill's Washington Report on Medicine & Health 40(28): Suppl 4 P.-Suppl 4 P.

Perspectives. Medical technology: can we stop the "arms race"?. Faulkner & Gray's Medicine & Health 47(36): Suppl 4 P.-Suppl 4 P.

Perspectives. Medical trash: nobody wants it. Mcgraw-Hill's Medicine & Health 42(30): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicare 'Mega-reg' adds to challenges faced by new plans hoping to compete. Medicine & Health 52(27): Suppl 1-4

Perspectives. Medicare HMO advocates fend off critics left and right. Faulkner & Gray's Medicine & Health 49(24): Suppl 1-4

Perspectives. Medicare HMOs fear risk adjustment will cut their payments. Medicine & Health 52(7): Suppl 1-4

Perspectives. Medicare Part C: an old idea takes new shape. Faulkner & Gray's Medicine & Health 48(24): Suppl 1-4

Perspectives. Medicare Rx debate: a few things seldom considered. Medicine & Health 55(17): Suppl 2 P.-Suppl 2 P.

Perspectives. Medicare and beneficiary income. Washington Report on Medicine & Health 39(12): Suppl 4p-Suppl 4p

Perspectives. Medicare at 25. Faulkner & Gray's Medicine & Health 44(31): Suppl 6 P.-Suppl 6 P.

Perspectives. Medicare buy-in: modest proposal kicks up big stir. Medicine & Health 52(3): Suppl 1-4

Perspectives. Medicare drugs and PBMs: a done deal, but still a tale of tradeoffs. Medicine & Health 54(38): Suppl 1-4

Perspectives. Medicare panel ponders tight congressional control of HCFA. Medicine & Health 52(24): Suppl 1-4

Perspectives. Medicare policy: capital punishment?. Mcgraw-Hill's Medicine & Health 43(8): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicare rate hike challenges hospices. Faulkner & Gray's Medicine & Health 44(2): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicare struggles to size up risks in capitated plans. Faulkner & Gray's Medicine & Health 49(25): Suppl 1-4

Perspectives. Medicare's pork barrel. Mcgraw-Hill's Medicine & Health 42(7): Suppl 4 P.-Suppl 4 P.

Perspectives. Medicare's silent partners: reform of contractor system slowed as Y2K tangle spotlights unheralded intermediaries. Medicine & Health 52(29): Suppl 1-4

Perspectives. Medicare, insurers, big employers begin to eye practice variations. Medicine & Health 55(12): Suppl 1-2

Perspectives. Medicare: sharing the costly burden. Washington Report on Medicine & Health 37(8): Suppl 4p-Suppl 4p

Perspectives. Medicare: should it--can it--be reformed?. Faulkner & Gray's Medicine & Health 49(3): Suppl 1-4

Perspectives. Medicare: twenty years later. Washington Report on Medicine & Health 39(29): Suppl 4p-Suppl 4p

Perspectives. Medicine & Health at 50: wheels of policy grind slowly. Faulkner & Gray's Medicine & Health 50(2): Suppl 1-4

Perspectives. Medigap industry under scrutiny. Mcgraw-Hill's Medicine & Health 43(24): Suppl 4 P.-Suppl 4 P.

Perspectives. Medigap market melee: next round. Faulkner & Gray's Medicine & Health 44(23): Suppl 4 P.-Suppl 4 P.

Perspectives. Medisave accounts: one small step toward health reform. Faulkner & Gray's Medicine & Health 47(45): Suppl 4 P.-Suppl 4 P.

Perspectives. Mental health care: reconciling parity and prejudice. Faulkner & Gray's Medicine & Health 47(46): Suppl 4 P.-Suppl 4 P.

Perspectives. Metropolitan hospitals: an urban tug of war. Faulkner & Gray's Medicine & Health 44(20): Suppl 4 P.-Suppl 4 P.

Perspectives. Midwest buyers seek provider-specific performance data. Faulkner & Gray's Medicine & Health 51(12): Suppl 1-4

Perspectives. Minnesota aims for health care utopia. Faulkner & Gray's Medicine & Health 46(32): Suppl 4 P.-Suppl 4 P.

Perspectives. Minority health: moving the mountain. Medicine & Health 43(45): Suppl 4 P.-Suppl 4 P.

Perspectives. Minority medical schools: rough sailing ahead. Faulkner & Gray's Medicine & Health 45(24): Suppl 4 P.-Suppl 4 P.

Perspectives. More heat than light in Medicare anti-fraud debate. Faulkner & Gray's Medicine & Health 49(35): Suppl 1-4

Perspectives. More money, more money, more money. Faulkner & Gray's Medicine & Health 46(4): Suppl 4 P.-Suppl 4 P.

Perspectives. Movement on the malpractice front. Faulkner & Gray's Medicine & Health 45(14): Suppl 4 P.-Suppl 4 P.

Perspectives. NCQA: setting the standard in setting the standard. Faulkner & Gray's Medicine & Health 50(35): Suppl 1-4

Perspectives. NMR challenges health planning. Washington Report on Medicine & Health 38(14): Suppl 4p-Suppl 4p

Perspectives. National health care: deja vu all over again. Mcgraw-Hill's Medicine & Health 43(39): Suppl 4 P.-Suppl 4 P.

Perspectives. Need for access to new drugs creates big challenge for state ADAP programs (AIDS Drug Assistance Programs); better coordination with Medicaid urged. Medicine & Health 53(11): Suppl 1-4

Perspectives. Negotiators round upward in final adjustments to BBA "refinement" bill. Medicine & Health 53(46): Suppl 1-4

Perspectives. New Jersey's journey from DRGs to deregulation. Faulkner & Gray's Medicine & Health 46(47): Suppl 4 P.-Suppl 4 P.

Perspectives. New PEW report stirs dialogue on future nursing workforce needs. Medicine & Health 52(17): Suppl 1-4

Perspectives. New chief at AHCPR has eclat, but not much cash. Faulkner & Gray's Medicine & Health 51(13): Suppl 1-4

Perspectives. New estimates credit managed care with savings, but upward pressures loom. Medicine & Health 52(37): Suppl 1-4

Perspectives. New governors face uninsured. Faulkner & Gray's Medicine & Health 44(46): Suppl 4 P.-Suppl 4 P.

Perspectives. New guidelines prescribe relief from pain. Faulkner & Gray's Medicine & Health 46(11): Suppl 4 P.-Suppl 4 P.

Perspectives. New hope for ventilator-dependent kids. Mcgraw-Hill's Medicine & Health 42(19): Suppl 4 P.-Suppl 4 P.

Perspectives. New ideas for Medicare risk, but Baltimore demo stumbles. Faulkner & Gray's Medicine & Health 50(27): Suppl 1-4

Perspectives. New lessons ahead for teaching hospitals. Washington Report on Medicine & Health 37(15): Suppl 4p-Suppl 4p

Perspectives. New safe harbors shelter few joint ventures. Faulkner & Gray's Medicine & Health 45(31): Suppl 4 P.-Suppl 4 P.

Perspectives. New twist on guideline dissemination stirs professional debate, gets slap from FDA. Medicine & Health 53(8): Suppl 1-4

Perspectives. No end in sight to rising premiums, Wall Streeters say. Medicine & Health 55(29): 7-8

Perspectives. Noninvasive surgery: George Bush & health reform. Faulkner & Gray's Medicine & Health 46(40): Suppl 6 P.-Suppl 6 P.

Perspectives. Nonprofit hospitals: a taxing issue. Mcgraw-Hill's Medicine & Health 43(4): Suppl 4 P.-Suppl 4 P.

Perspectives. Numbers game: uncertainties in long-term spending forecasts return to haunt bipartisan Medicare Commission. Medicine & Health 53(4): Suppl 1-4

Perspectives. Nurse layoffs and hospitals: changing the course of care. Faulkner & Gray's Medicine & Health 49(11): Suppl 1-4

Perspectives. Nurses bypass hospital careers. Mcgraw-Hill's Medicine & Health 41(19): Suppl 4 P.-Suppl 4 P.

Perspectives. Nursing home standards: flashpoint for federalism. Faulkner & Gray's Medicine & Health 49(42): Suppl 1-4

Perspectives. Nursing homes: quality concerns reappear. Mcgraw-Hill's Medicine & Health 41(38): Suppl 4 P.-Suppl 4 P.

Perspectives. Nursing homes: quality of care. Mcgraw-Hill's Washington Report on Medicine & Health 40(11): Suppl 4 P.-Suppl 4 P.

Perspectives. Nursing sentinel events key to quality, safety. Medicine & Health 55(22): 7-8

Perspectives. Nursing shortage: not cyclical this time around. Medicine & Health 55(16): Suppl 2 P.-Suppl 2 P.

Perspectives. Nursing struggles with identity in face of shortage. Medicine & Health 55(18): 7-8

Perspectives. Nursing tackles new roles in changing health system. Faulkner & Gray's Medicine & Health 48(20): Suppl 4 P.-Suppl 4 P.

Perspectives. Nutrition is a part of care, but ... at the hospital it counts last. Soins; la Revue de Reference Infirmiere: 48-48

Perspectives. OMB plans to slash research funding. Mcgraw-Hill's Washington Report on Medicine & Health 40(14): Suppl 4 P.-Suppl 4 P.

Perspectives. Online sales no cure for uninsured, analysts say. Medicine & Health 55(26): 7-8

Perspectives. Opening the borders to Hispanic health. Faulkner & Gray's Medicine & Health 45(16): Suppl 4 P.-Suppl 4 P.

Perspectives. Opposing lobbies gird for battle over PSOs. Faulkner & Gray's Medicine & Health 51(5): Supp 1-Su2, 4

Perspectives. Options vs. limits: drug cost strategies reconsidered. Faulkner & Gray's Medicine & Health 51(38): Suppl 4-Suppl 4

Perspectives. Oregon's recipe for health care rationing. Faulkner & Gray's Medicine & Health 44(19): Suppl 4 P.-Suppl 4 P.

Perspectives. Orphan Drug Act stumps lawmakers. Faulkner & Gray's Medicine & Health 44(25): Suppl 4 P.-Suppl 4 P.

Perspectives. Otis Bowen, the reluctant Secretary. Mcgraw-Hill's Medicine & Health 41(40): Suppl 4 P.-Suppl 4 P.

Perspectives. Outcomes hard to track in kids' behavioral care. Faulkner & Gray's Medicine & Health 51(3): Suppl 1-4

Perspectives. Outcomes measurement: are collaboration, standardization still distant goals?. Medicine & Health 53(37): Suppl 1-4

Perspectives. PHOs abound, but most are works in progress. Faulkner & Gray's Medicine & Health 49(40): Suppl 1-4

Perspectives. POS proposals promise choice, may be cheap; but loopholes abound and "nobody is paying any attention". Medicine & Health 52(30): Suppl 1-4

Perspectives. PPOs face antitrust problems. Washington Report on Medicine & Health 38(44): Suppl 4p-Suppl 4p

Perspectives. PPOs: insurers, employers get more involved. Mcgraw-Hill's Medicine & Health 42(47): Suppl 6 P.-Suppl 6 P.

Perspectives. PPRC comes up to bat with reform recommendations. Faulkner & Gray's Medicine & Health 48(22): Suppl 4 P.-Suppl 4 P.

Perspectives. PPRC issues '95 report; Wilensky takes the helm. Faulkner & Gray's Medicine & Health 49(15): Suppl 1-4

Perspectives. PPS: learning from the past. Mcgraw-Hill's Medicine & Health 43(5): Suppl 4 P.-Suppl 4 P.

Perspectives. PRO goals: realistic or risky?. Washington Report on Medicine & Health 31(32): Suppl 4p-Suppl 4p

Perspectives. PROs at the starting gate. Washington Report on Medicine & Health 38(10): Suppl 4p-Suppl 4p

Perspectives. PROs set to go. Washington Report on Medicine & Health 38(45): Suppl 4p-Suppl 4p

Perspectives. PROs: Medicare's paper tigers?. Mcgraw-Hill's Medicine & Health 42(44): Suppl 4 P.-Suppl 4 P.

Perspectives. PROs: modification and expansion. Washington Report on Medicine & Health 39(33): Suppl 4 P.-Suppl 4 P.

Perspectives. PROs: struggling to define the rules of the game. Faulkner & Gray's Medicine & Health 44(3): Suppl 4 P.-Suppl 4 P.

Perspectives. PSNs (provider sponsored networks): nifty concept, thorny complications. Faulkner & Gray's Medicine & Health 49(39): Suppl 1-4

Perspectives. Pain Act: for foes and supporters a matter of, first, do no harm. Medicine & Health 54(19): Suppl 1-4

Perspectives. Paradoxes of medical rehabilitation. Mcgraw-Hill's Medicine & Health 41(45): Suppl 4 P.-Suppl 4 P.

Perspectives. Partnership rules: stark black and white. Part two. Mcgraw-Hill's Medicine & Health 43(14): Suppl 4 P.-Suppl 4 P.

Perspectives. Patient dumping mars competitive model. Washington Report on Medicine & Health 39(28): Suppl 4p-Suppl 4p

Perspectives. Patient dumping: on the rise?. Mcgraw-Hill's Medicine & Health 42(20): Suppl 4 P.-Suppl 4 P.

Perspectives. Patient protection: key differences emerge on information, appeals, access, and scope provisions; but bills languish. Medicine & Health 52(36): Suppl 1-4

Perspectives. Paying physicians differently, Part one. Washington Report on Medicine & Health 39(7): Suppl 4p-Suppl 4p

Perspectives. Paying physicians differently, Part two. Washington Report on Medicine & Health 39(8): Suppl 4p-Suppl 4p

Perspectives. Peer review of ambulatory care. Mcgraw-Hill's Medicine & Health 41(35): Suppl 4 P.-Suppl 4 P.

Perspectives. Peer review program takes shape. Washington Report on Medicine & Health 37(37): 4p-4p

Perspectives. People problems plague switch to chronic care models. Medicine & Health 56(3): 7-8

Perspectives. Pepper salts long-term care debate. Mcgraw-Hill's Medicine & Health 42(23): Suppl 4 P.-Suppl 4 P.

Perspectives. Pepper watchers hopes dashed. Faulkner & Gray's Medicine & Health 44(10): Suppl 4 P.-Suppl 4 P.

Perspectives. Perestroika at Hopkins: new environment in microcosm. Faulkner & Gray's Medicine & Health 49(26): Suppl 1-4

Perspectives. Performance measurement: health reform's hope or hype?. Faulkner & Gray's Medicine & Health 47(44): Suppl 4 P.-Suppl 4 P.

Perspectives. Physician organizations struggle over questions of size and structure. Medicine & Health 53(2): Suppl 1-4

Perspectives. Physician payment reform: on the brink. Mcgraw-Hill's Medicine & Health 43(12): Suppl 4 P.-Suppl 4 P.

Perspectives. Physician payment reform: struggling to be born. Faulkner & Gray's Medicine & Health 45(1): Suppl 4 P.-Suppl 4 P.

Perspectives. Physician payment reform: the ultimate solution?. Faulkner & Gray's Medicine & Health 44(6): Suppl 4 P.-Suppl 4 P.

Perspectives. Physician payment: HCFA eyes capitation. Washington Report on Medicine & Health 39(50): Suppl 4 P.-Suppl 4 P.

Perspectives. Physician payments: Medicare's next battleground. Mcgraw-Hill's Medicine & Health 41(42): Suppl 4 P.-Suppl 4 P.

Perspectives. Physician performance measurement initiatives gain ground. Medicine & Health 52(40): Suppl 1-4

Perspectives. Physician unions for a changing market. Mcgraw-Hill's Washington Report on Medicine & Health 40(8): Suppl 4 P.-Suppl 4 P.

Perspectives. Physicians and hospitals joining forces to stake out market share. Faulkner & Gray's Medicine & Health 48(9): Suppl 4 P.-Suppl 4 P.

Perspectives. Physicians in training eye new world of health reform. Faulkner & Gray's Medicine & Health 48(19): Suppl 1-4

Perspectives. Physicians, consumers lock horns on peer review. Mcgraw-Hill's Medicine & Health 41(17): Suppl 4 P.-Suppl 4 P.

Perspectives. Pitfalls for retiree health plans. Mcgraw-Hill's Medicine & Health 41(47): Suppl 4 P.-Suppl 4 P.

Perspectives. Placing the patient back into the center of the health care system. Soins; la Revue de Reference Infirmiere: 23-23

Perspectives. Plans follow employers in search of wellness dollars. Faulkner & Gray's Medicine & Health 51(29): Suppl 1-4

Perspectives. Point-of-sale: problem or promise?. Mcgraw-Hill's Medicine & Health 43(29): Suppl 4 P.-Suppl 4 P.

Perspectives. Policymakers grapple with foundations of process for coverage decisions, appeals. Medicine & Health 53(18): Suppl 1-4

Perspectives. Practice guidelines: more than attitudes will have to change. Faulkner & Gray's Medicine & Health 49(20): Suppl 1-4

Perspectives. Practice style: key to health care costs?. Washington Report on Medicine & Health 38(30): Suppl 4p-Suppl 4p

Perspectives. Practice-based research targets nuances of everyday care. Faulkner & Gray's Medicine & Health 51(37): Suppl 1-4

Perspectives. Preferred providers proliferate. Washington Report on Medicine & Health 37(25): 4p-4p

Perspectives. Preferred providers: discount health care. Washington Report on Medicine & Health: Suppl 4 P.-Suppl 4 P.

Perspectives. Premium support: a fluid concept accommodates contrary viewpoints as Medicare reformers toil on. Medicine & Health 53(3): Suppl 1-4

Perspectives. Prenatal care programs gain support. Mcgraw-Hill's Washington Report on Medicine & Health 40(25): Suppl 4 P.-Suppl 4 P.

Perspectives. Prenatal care: rationing the risks. Faulkner & Gray's Medicine & Health 43(47): Suppl 4 P.-Suppl 4 P.

Perspectives. President Bush's election year budget. Faulkner & Gray's Medicine & Health 46(5): Suppl 6 P.-Suppl 6 P.

Perspectives. President Clinton: what will it mean?. Faulkner & Gray's Medicine & Health 46(44): Suppl 4 P.-Suppl 4 P.

Perspectives. Presidential runners tackle health issues. Part 1. Mcgraw-Hill's Medicine & Health 41(49): Suppl 4 P.-Suppl 4 P.

Perspectives. Primary care moves into prime time. Faulkner & Gray's Medicine & Health 47(30): Suppl 4 P.-Suppl 4 P.

Perspectives. Privacy goes public: protecting medical records. Faulkner & Gray's Medicine & Health 48(27): Suppl 1-4

Perspectives. Private psychiatric hospital outlook. Washington Report on Medicine & Health 39(42): Suppl 4 P.-Suppl 4 P.

Perspectives. Private sector solutions for the uninsured. Mcgraw-Hill's Medicine & Health 42(6): Suppl 4 P.-Suppl 4 P.

Perspectives. ProPAC & hospitals: agreeing to disagree. Faulkner & Gray's Medicine & Health 44(11): Suppl 4 P.-Suppl 4 P.

Perspectives. ProPAC recommends payment hike. Mcgraw-Hill's Washington Report on Medicine & Health 40(15): Suppl 4 P.-Suppl 4 P.

Perspectives. ProPAC speaks out. Washington Report on Medicine & Health 39(14): Suppl 4p-Suppl 4p

Perspectives. ProPAC takes a turn to the right. Mcgraw-Hill's Medicine & Health 41(15): Suppl 4 P.-Suppl 4 P.

Perspectives. ProPAC's report to Congress. Mcgraw-Hill's Washington Report on Medicine & Health 40(10): Suppl 4 P.-Suppl 4 P.

Perspectives. Product liability reform: an uphill battle. Faulkner & Gray's Medicine & Health 44(7): Suppl 4 P.-Suppl 4 P.

Perspectives. Progress ahead for family planning. Mcgraw-Hill's Medicine & Health 40(48): Suppl 4 P.-Suppl 4 P.

Perspectives. Promises and pitfalls in public health strategy for suicide prevention. Medicine & Health 54(44): Suppl 1-4

Perspectives. Proposal is down payment on long-term Bush Medicare vision. Medicine & Health 56(5): 7-8

Perspectives. Proprietary hospitals: strategies for survival. Mcgraw-Hill's Medicine & Health 40(38): Suppl 4 P.-Suppl 4 P.

Perspectives. Prospective payment: DRG era dawns. Washington Report on Medicine & Health 37(35): 4p-4p

Perspectives. Prospective rates: regional, three-year phase-in. Washington Report on Medicine & Health 37(10): Suppl 4p-Suppl 4p

Perspectives. Protecting home and community-based waivers. Mcgraw-Hill's Washington Report on Medicine & Health 40(24): Suppl 4 P.-Suppl 4 P.

Perspectives. Provider-based insurance. Washington Report on Medicine & Health 39(13): Suppl 4p-Suppl 4p

Perspectives. Providers eye flat tax proposals. Washington Report on Medicine & Health 38(49): Suppl 4p-Suppl 4p

Perspectives. Public health and managed care find common ground. Faulkner & Gray's Medicine & Health 49(33): Suppl 1-4

Perspectives. Public health attacks violence. Faulkner & Gray's Medicine & Health 46(25): Suppl 4 P.-Suppl 4 P.

Perspectives. Public health: an unsung hero at risk. Faulkner & Gray's Medicine & Health 48(36): Suppl 1-4

Perspectives. Public hospitals seek fiscal relief. Washington Report on Medicine & Health 37(39): Suppl 4p-Suppl 4p

Perspectives. Public hospitals struggle to stay afloat. Mcgraw-Hill's Medicine & Health 41(46): Suppl 4 P.-Suppl 4 P.

Perspectives. Push for new directions in quality assurance. Faulkner & Gray's Medicine & Health 44(26): Suppl 4 P.-Suppl 4 P.

Perspectives. Putting 'systems-based practice' in the med school curriculum. Medicine & Health 54(4): Suppl 1-4

Perspectives. Putting health care to a vote. Washington Report on Medicine & Health 38(44): Suppl 4p-Suppl 4p

Perspectives. Quality data: how good is it?. Mcgraw-Hill's Medicine & Health 43(3): Suppl 4 P.-Suppl 4 P.

Perspectives. Quality, output gains belie some health cost estimates. Medicine & Health 52(5): Suppl 1-4

Perspectives. Reagan budget: competition, more cuts. Washington Report on Medicine & Health 37(6): Suppl 8p-Suppl 8p

Perspectives. Reagan budget: health takes center stage. Mcgraw-Hill's Medicine & Health 41(2): Suppl 6 P.-Suppl 6 P.

Perspectives. Reagan budget: here we go again. Mcgraw-Hill's Washington Report on Medicine & Health 40(6): Suppl 8 P.-Suppl 8 P.

Perspectives. Reagan budget: what's new?. Washington Report on Medicine & Health 38(6): Suppl 6p-Suppl 6p

Perspectives. Reagan health policy in transition. Washington Report on Medicine & Health 39(35): Suppl 4p-Suppl 4p

Perspectives. Reagan, Congress rap about physicians. Mcgraw-Hill's Medicine & Health 41(4): Suppl 4 P.-Suppl 4 P.

Perspectives. Reassessing technology. Washington Report on Medicine & Health 38(20): Suppl 4p-Suppl 4p

Perspectives. Recession to bring minimal Medicaid cuts, impetus to reform?. Medicine & Health 55(43): 7-8

Perspectives. Reconciliation: good news and bad. Mcgraw-Hill's Medicine & Health 40(40): Suppl 4 P.-Suppl 4 P.

Perspectives. Reconciliation: good tidings for providers. Mcgraw-Hill's Medicine & Health 40(30): Suppl 4 P.-Suppl 4 P.

Perspectives. Referrals for sale. Mcgraw-Hill's Medicine & Health 42(39): Suppl 4 P.-Suppl 4 P.

Perspectives. Reformers' next challenge: shaping the public will. Faulkner & Gray's Medicine & Health 47(20): Suppl 4 P.-Suppl 4 P.

Perspectives. Reforming malpractice law. Washington Report on Medicine & Health 39(38): Suppl 4 P.-Suppl 4 P.

Perspectives. Reforms don't protect group purchasing schemes from marketplace vicissitudes. Medicine & Health 53(20): Suppl 1-4

Perspectives. Regression to the mean: PPOs, risk-sharing are market mainstays. Medicine & Health 54(13): Supppl 1-4

Perspectives. Regs awaited as telemedicine braces for life after subsidies. Faulkner & Gray's Medicine & Health 51(15): Suppl 1-4

Perspectives. Regulation in the market: friend or foe of competition?. Medicine & Health 52(11): Suppl 1-4

Perspectives. Regulation run amok? Stark II proposal draws cacophony of comment. Medicine & Health 52(33): Suppl 1-4

Perspectives. Rehab accreditors looking for more than just outcomes data. Medicine & Health 53(34): Suppl 1-4

Perspectives. Religious hospitals juggle mission. Mcgraw-Hill's Washington Report on Medicine & Health 40(17): Suppl 4 P.-Suppl 4 P.

Perspectives. Renegotiating the social contract in public health. Faulkner & Gray's Medicine & Health 50(31): Suppl 1-4

Perspectives. Reports from the field suggest some quality tools work best at local level. Medicine & Health 53(22): Suppl 1-4

Perspectives. Reproductive rights: will the debate engulf reform?. Faulkner & Gray's Medicine & Health 48(13): Suppl 4 P.-Suppl 4 P.

Perspectives. Republicans inherit quest for answers on health costs. Faulkner & Gray's Medicine & Health 49(21): Suppl 1-4

Perspectives. Research emphasis puts bipartisan face on Clinton budget. Medicine & Health 52(6): Suppl 1-4

Perspectives. Researchers call for renewed efforts in the war on cancer. Faulkner & Gray's Medicine & Health 48(44): Suppl 1-4

Perspectives. Researchers protest congressional "meddling". Faulkner & Gray's Medicine & Health 46(45): Suppl 4 P.-Suppl 4 P.

Perspectives. Responses to the AIDS crisis. Washington Report on Medicine & Health 39(41): Suppl 4 P.-Suppl 4 P.

Perspectives. Restructuring physician payment. Washington Report on Medicine & Health 38(29): Suppl 4p-Suppl 4p

Perspectives. Retiree health benefits come under the knife. Faulkner & Gray's Medicine & Health 47(17): Suppl 4 P.-Suppl 4 P.

Perspectives. Revenues drop, health spending rises: what's a state to do?. Medicine & Health 55(42): 7-8

Perspectives. Rhode Island tries to do the "RIte" thing. Faulkner & Gray's Medicine & Health 48(32): Suppl 1-4

Perspectives. Right-to-die cases stir profound ethics controversy. First of two articles. Faulkner & Gray's Medicine & Health 50(41): Suppl 1-4

Perspectives. Risky business: Maryland's new Medicaid program. Faulkner & Gray's Medicine & Health 51(33): Suppl 1-4

Perspectives. Road to Medicare FFS reform leads through middle ground occupied by private contractors. Medicine & Health 53(30): Suppl 1-4

Perspectives. Road to integration leads to community health, too. Faulkner & Gray's Medicine & Health 50(5): Suppl 1-4

Perspectives. Rural care not on life support, but PPS changes needed. Medicine & Health 55(24): 7-8

Perspectives. Rural health at a cross roads. Faulkner & Gray's Medicine & Health 45(4): Suppl 4 P.-Suppl 4 P.

Perspectives. Rural help on the way. Faulkner & Gray's Medicine & Health 44(42): Suppl 4 P.-Suppl 4 P.

Perspectives. Rural hospitals in jeopardy?. Mcgraw-Hill's Medicine & Health 40(32): Suppl 4 P.-Suppl 4 P.

Perspectives. Rural hospitals sink or swim. Mcgraw-Hill's Medicine & Health 43(19): Suppl 4 P.-Suppl 4 P.

Perspectives. Rural hospitals' dependence on subacute care revenues increases risks from PPS. Medicine & Health 53(41): Suppl 1-4

Perspectives. SCHIP premium subsidy plans stymied by HCFA's rigid stance. Medicine & Health 54(16): Suppl 1-4

Perspectives. SCHIP's (State Children's Health Insurance Program) success inspires incrementalists to pursue ideas for expanding coverage; tax-based proposals draw fresh interest. Medicine & Health 53(10): Suppl 1-4

Perspectives. Safety-net providers surviving, but dependence on subsidies is ominous. Medicine & Health 53(44): Suppl 1-4

Perspectives. Salaried doctors turn to unions to stem losses of income, autonomy. Medicine & Health 53(25): Suppl 1-4

Perspectives. Satcher Report: research is key to overcoming stigma and widespread undertreatment of mental disorders. Medicine & Health 54(3): Suppl 1-4

Perspectives. Saving infants' lives. Faulkner & Gray's Medicine & Health 44(36): Suppl 4 P.-Suppl 4 P.

Perspectives. Saying the unsayable: health care rationing. Faulkner & Gray's Medicine & Health 47(40): Suppl 4 P.-Suppl 4 P.

Perspectives. School-based clinics spawn controversy. Mcgraw-Hill's Medicine & Health 42(48): Suppl 4 P.-Suppl 4 P.

Perspectives. Schweiker sends DRG-based plan to Congress. Washington Report on Medicine & Health 37(1): Suppl 4p-Suppl 4p

Perspectives. Searching for small market reforms. Faulkner & Gray's Medicine & Health 45(17): Suppl 4 P.-Suppl 4 P.

Perspectives. Seeking a cure for violence among America's youth. Faulkner & Gray's Medicine & Health 50(10): Suppl 1-4

Perspectives. Seeking sharper focus on hospital, HMO ownership issues. Faulkner & Gray's Medicine & Health 50(43): Suppl 1-4

Perspectives. Senate cuts some slack to beleaguered HMO industry. Medicine & Health 53(29): 1-4

Perspectives. Severity of illness and hospital payment. Washington Report on Medicine & Health 39(10): Suppl 4p-Suppl 4p

Perspectives. Shopping for bypass discounts. Mcgraw-Hill's Medicine & Health 41(37): Suppl 4 P.-Suppl 4 P.

Perspectives. Shortage amid plenty complicates task of redefining underserved areas. Medicine & Health 52(41): Suppl 1-4

Perspectives. Should psychiatric coverage shrink?. Mcgraw-Hill's Medicine & Health 41(9): Suppl 4 P.-Suppl 4 P.

Perspectives. Shrinking private system maroons the uninsured. Faulkner & Gray's Medicine & Health 50(18): Suppl 1-4

Perspectives. Size of hospital cuts soon to sink in back home. Faulkner & Gray's Medicine & Health 49(41): Suppl 1-4

Perspectives. Slow progress against infant mortality. Faulkner & Gray's Medicine & Health 46(19): Suppl 4 P.-Suppl 4 P.

Perspectives. Slowed growth signals changing environment for Medicaid HMOs. Faulkner & Gray's Medicine & Health 51(1): Suppl 1-4

Perspectives. Socioeconomic inequality: new lead player on public health research stage. Medicine & Health 54(46): Suppl 1-4

Perspectives. Solution gap looms for financing baby boomers' future long-term care needs. Medicine & Health 52(12): Suppl 1-4

Perspectives. Some applaud House appeals rules; states are leery. Medicine & Health 55(32): 7-8

Perspectives. State indigent care initiatives. Washington Report on Medicine & Health 39(43): Suppl 4 P.-Suppl 4 P.

Perspectives. States and Feds struggle to mesh care for dual eligibles. Faulkner & Gray's Medicine & Health 50(17): Suppl 1-4

Perspectives. States blend Medicaid, homegrown concepts in kidcare plans. Medicine & Health 52(9): Suppl 1-4

Perspectives. States exploring new roles as catalysts in GME restructuring. Faulkner & Gray's Medicine & Health 51(36): Suppl 1-4

Perspectives. States eye reform in 1995: is the glass half-empty?. Faulkner & Gray's Medicine & Health 49(2): Suppl 1-4

Perspectives. States eye tobacco settlement money: public health bonanza or free-for-all?. Medicine & Health 53(13): Suppl 1-4

Perspectives. States find no easy answers on Medicaid behavioral care. Faulkner & Gray's Medicine & Health 51(22): Suppl 1-4

Perspectives. States forge ahead of feds on parity. Medicine & Health 51(48): Suppl 1-4

Perspectives. States look to DRGs for Medicaid cure. Washington Report on Medicine & Health 38(22): Suppl 4p-Suppl 4p

Perspectives. States mix and match options in new child health programs. Faulkner & Gray's Medicine & Health 51(40): Suppl 1-4

Perspectives. States rediscover certificate-of-need laws. Faulkner & Gray's Medicine & Health 47(8): Suppl 4 P.-Suppl 4 P.

Perspectives. States respond to capital question. Washington Report on Medicine & Health 37(14): Suppl 4p-Suppl 4p

Perspectives. States slow Medicaid growth. Washington Report on Medicine & Health 38(36): Suppl 4p-Suppl 4p

Perspectives. States struggle to piece together puzzle of uninsured. Medicine & Health 55(3): Suppl 1-4

Perspectives. States turn to all-payer systems. Washington Report on Medicine & Health 37(42): Suppl 4p-Suppl 4p

Perspectives. States use upper payment limit to snag federal Medicaid dollars. Medicine & Health 54(45): Suppl 1-4

Perspectives. States, courts inch forward on HMO liability while conferees' debate nears. Medicine & Health 53(43): Suppl 1-4

Perspectives. Stock ownership: sullying research purity?. Faulkner & Gray's Medicine & Health 47(6): Suppl 4 P.-Suppl 4 P.

Perspectives. Strapped governments eye nonprofit hospitals. Faulkner & Gray's Medicine & Health 47(31): Suppl 4 P.-Suppl 4 P.

Perspectives. Structured settlements: everybody wins. Faulkner & Gray's Medicine & Health 46(22): Suppl 4 P.-Suppl 4 P.

Perspectives. Struggling choices demo full of warning signs for aspiring Medicare PSOs. Medicine & Health 52(13): Suppl 1-4

Perspectives. Sub-acute care gets prospective payment--in four flavors. Faulkner & Gray's Medicine & Health 51(28): Suppl 1-4

Perspectives. Sub-acute payment changes hint at brave new world of outcomes. Medicine & Health 52(15): Suppl 1-4

Perspectives. Substance abuse treatment not a priority for most health plans. Faulkner & Gray's Medicine & Health 50(28): Suppl 1-4

Perspectives. Sullivan: is he tough enough?. Mcgraw-Hill's Medicine & Health 43(26): Suppl 4 P.-Suppl 4 P.

Perspectives. Supreme Court ruling opens Pandora's Box. Faulkner & Gray's Medicine & Health 45(23): Suppl 4 P.-Suppl 4 P.

Perspectives. Surgeon General nominee ignites controversy. Faulkner & Gray's Medicine & Health 47(33): Suppl 4 P.-Suppl 4 P.

Perspectives. Surgery proposed for outpatient rates. Washington Report on Medicine & Health 39(34): Suppl 4p-Suppl 4p

Perspectives. Surplus makes both 'restraint,' new programs possible in budget proposal. Medicine & Health 54(7): Suppl 1-4

Perspectives. Swallow some contradictions and call me in the morning. Medicine & Health 55(45): 7-8

Perspectives. Swedes test capitalist waters in new health systems reform. Faulkner & Gray's Medicine & Health 48(10): Suppl 4 P.-Suppl 4 P.

Perspectives. Systemwide reforms needed to cure health ills. Faulkner & Gray's Medicine & Health 47(28): Suppl 4 P.-Suppl 4 P.

Perspectives. Tackling physician payment reform. Mcgraw-Hill's Medicine & Health 42(16): Suppl 4 P.-Suppl 4 P.

Perspectives. Taking a cue from Britain's NHS. Faulkner & Gray's Medicine & Health 44(18): Suppl 6 P.-Suppl 6 P.

Perspectives. Taking back the BBA, 2001 edition: hello, telehealth; goodbye, UPL loophole. Medicine & Health 55(2): Suppl 1-4

Perspectives. Taking the public's health care pulse. Faulkner & Gray's Medicine & Health 44(35): Suppl 4 P.-Suppl 4 P.

Perspectives. Tasks ahead as Congress, HHS look to reshape Medicare. Medicine & Health 55(25): 7-8

Perspectives. Tax bill tolls for providers. Washington Report on Medicine & Health 39(47): Suppl 4 P.-Suppl 4 P.

Perspectives. Tax credits: a paradise with snakes. Faulkner & Gray's Medicine & Health 46(14): Suppl 4 P.-Suppl 4 P.

Perspectives. Tax exclusion cap is back. Washington Report on Medicine & Health 37(3): Suppl 4p-Suppl 4p

Perspectives. Tax reform tastes sweet to providers. Mcgraw-Hill's Medicine & Health 40(34): Suppl 4 P.-Suppl 4 P.

Perspectives. Tax reform: a net plus for health providers. Mcgraw-Hill's Medicine & Health 41(11): Suppl 4 P.-Suppl 4 P.

Perspectives. Tax reform: the final days. Mcgraw-Hill's Washington Report on Medicine & Health 40(27): Suppl 4 P.-Suppl 4 P.

Perspectives. Teaching hospitals meet proprietary chains. Washington Report on Medicine & Health 39(9): Suppl 4p-Suppl 4p

Perspectives. Technology assessment's winding road. Faulkner & Gray's Medicine & Health 44(16): Suppl 4 P.-Suppl 4 P.

Perspectives. Technology assessment: a stronger federal role?. Faulkner & Gray's Medicine & Health 45(48): Suppl 4 P.-Suppl 4 P.

Perspectives. Technology: who shall judge?. Washington Report on Medicine & Health 37(24): Suppl 4p-Suppl 4p

Perspectives. Teen pregnancy: too late to bolt the door. Faulkner & Gray's Medicine & Health 47(42): Suppl 4 P.-Suppl 4 P.

Perspectives. Telemedicine races against time to earn its keep. Faulkner & Gray's Medicine & Health 49(47): Suppl 1-4

Perspectives. TennCare on the edge: can reformers fix it--before it's too late?. Medicine & Health 54(49): Suppl 1-4

Perspectives. TennCare's "shock therapy" worries doctors, patients. Faulkner & Gray's Medicine & Health 48(3): Suppl 4 P.-Suppl 4 P.

Perspectives. Terrorism event no time to be learning on the job. Medicine & Health 55(39): 7-8

Perspectives. The '96 elections. A fight for the center on Medicare. Faulkner & Gray's Medicine & Health 50(44): Suppl 1-4

Perspectives. The AIDS epidemic: crisis or challenge?. Mcgraw-Hill's Medicine & Health 40(45): Suppl 4 P.-Suppl 4 P.

Perspectives. The AMA after Sunbeam: tremor in the house of medicine. Medicine & Health 52(4): Suppl 1-4

Perspectives. The AMA: not going gently into a new day. Faulkner & Gray's Medicine & Health 47(48): Suppl 4 P.-Suppl 4 P.

Perspectives. The Clinton budget: preventive health gets prime time. Faulkner & Gray's Medicine & Health 47(16): Suppl 4 P.-Suppl 4 P.

Perspectives. The FY95 budget for HHS: tough medicine while waiting for the cure. Faulkner & Gray's Medicine & Health 48(7): Suppl 4 P.-Suppl 4 P.

Perspectives. The FY96 Clinton budget: setting the stage for a battle. Faulkner & Gray's Medicine & Health 49(7): Suppl 1-4

Perspectives. The Grand Old Party and health reform. Faulkner & Gray's Medicine & Health 47(39): Suppl 4 P.-Suppl 4 P.

Perspectives. The Health Service Corps: endangered species?. Mcgraw-Hill's Medicine & Health 42(27): Suppl 4 P.-Suppl 4 P.

Perspectives. The Indian Health Service: a flawed diamond. Faulkner & Gray's Medicine & Health 46(9): Suppl 4 P.-Suppl 4 P.

Perspectives. The Los Angeles market: "managed competition" at work. Faulkner & Gray's Medicine & Health 48(45): Suppl 1-4

Perspectives. The Nation's drug war. Mcgraw-Hill's Medicine & Health 40(46): Suppl 4 P.-Suppl 4 P.

Perspectives. The Patrick case: implications for peer review. Mcgraw-Hill's Medicine & Health 42(22): Suppl 4 P.-Suppl 4 P.

Perspectives. The Peachtree State strolls toward health reform. Faulkner & Gray's Medicine & Health 48(15): Suppl 4 P.-Suppl 4 P.

Perspectives. The Ryan White CARE (Comprehensive AIDS Resources Emergency) Act: facing its first crossroad. Faulkner & Gray's Medicine & Health 49(10): Suppl 1-4

Perspectives. The U.S. contraceptive gap. Faulkner & Gray's Medicine & Health 45(19): Suppl 4 P.-Suppl 4 P.

Perspectives. The VA health budget squeeze. Washington Report on Medicine & Health 39(21): Suppl 4p-Suppl 4p

Perspectives. The VA's blueprint for the future. Mcgraw-Hill's Medicine & Health 40(36): Suppl 4 P.-Suppl 4 P.

Perspectives. The all-payer waiver controversy. Washington Report on Medicine & Health 38(43): Suppl 4p-Suppl 4p

Perspectives. The battle over nursing home reform. Faulkner & Gray's Medicine & Health 45(12): Suppl 4 P.-Suppl 4 P.

Perspectives. The beleaguered Blues. Faulkner & Gray's Medicine & Health 46(34): Suppl 4 P.-Suppl 4 P.

Perspectives. The booming hospice industry. Mcgraw-Hill's Medicine & Health 41(16): Suppl 4 P.-Suppl 4 P.

Perspectives. The changing face of Medicaid. Washington Report on Medicine & Health 37(26): 4p-4p

Perspectives. The children's crusade. Mcgraw-Hill's Medicine & Health 43(10): Suppl 4 P.-Suppl 4 P.

Perspectives. The chronically ill and reform: a minefield of opportunities. Faulkner & Gray's Medicine & Health 48(31): Suppl 1-4

Perspectives. The continuing saga of Baby Doe. Washington Report on Medicine & Health 38(32): Suppl 4p-Suppl 4p

Perspectives. The corporatization of American health care. Washington Report on Medicine & Health 37(45): Suppl 4p-Suppl 4p

Perspectives. The expanding role of peer review. Mcgraw-Hill's Medicine & Health 40(50): Suppl 4 P.-Suppl 4 P.

Perspectives. The fraud busters. Mcgraw-Hill's Medicine & Health 42(26): Suppl 4 P.-Suppl 4 P.

Perspectives. The fully integrated health care company. Washington Report on Medicine & Health 39(25): Suppl 4p-Suppl 4p

Perspectives. The future of home care. Mcgraw-Hill's Medicine & Health 42(13): Suppl 4 P.-Suppl 4 P.

Perspectives. The future of hospice care. Mcgraw-Hill's Medicine & Health 40(37): Suppl 4 P.-Suppl 4 P.

Perspectives. The good, the bad, the incomplete: Medicare's fee schedule. Faulkner & Gray's Medicine & Health 46(6): Suppl 4 P.-Suppl 4 P.

Perspectives. The great American vaccine shortage. Washington Report on Medicine & Health 39(2): Suppl 4p-Suppl 4p

Perspectives. The health of the nation: mixed. Faulkner & Gray's Medicine & Health 46(29): Suppl 4 P.-Suppl 4 P.

Perspectives. The hospital role in post-discharge planning. Faulkner & Gray's Medicine & Health 44(9): Suppl 4 P.-Suppl 4 P.

Perspectives. The hospital work force: changing with the times. Faulkner & Gray's Medicine & Health 48(23): Suppl 1-4

Perspectives. The impact of managed care on behavioral providers. Faulkner & Gray's Medicine & Health 51(32): Suppl 1-4

Perspectives. The long, winding road to integration of alternative and conventional medicine. Medicine & Health 53(21): Suppl 1-4

Perspectives. The looming Medicare crisis. Washington Report on Medicine & Health 37(49): Suppl 4p-Suppl 4p

Perspectives. The nation's health: stumbling to the goal line. Mcgraw-Hill's Medicine & Health 41(7): Suppl 4 P.-Suppl 4 P.

Perspectives. The new frugality: hard decisions for States. Mcgraw-Hill's Washington Report on Medicine & Health 40(19): Suppl 4 P.-Suppl 4 P.

Perspectives. The perils of competition. Mcgraw-Hill's Medicine & Health 42(36): Suppl 4 P.-Suppl 4 P.

Perspectives. The politics of research. Mcgraw-Hill's Medicine & Health 41(13): Suppl 4 P.-Suppl 4 P.

Perspectives. The pursuit of quality. Mcgraw-Hill's Medicine & Health 42(28): Suppl 4 P.-Suppl 4 P.

Perspectives. The rebirth of the Blues. Faulkner & Gray's Medicine & Health 45(7): Suppl 4 P.-Suppl 4 P.

Perspectives. The rules of the game in health care lobbying. Faulkner & Gray's Medicine & Health 45(33): Suppl 4 P.-Suppl 4 P.

Perspectives. The search for a quality measure. Mcgraw-Hill's Medicine & Health 41(34): Suppl 4 P.-Suppl 4 P.

Perspectives. The single payer solution: now, later, or never?. Faulkner & Gray's Medicine & Health 48(17): Suppl 1-4

Perspectives. The sizzle without the steak: Bush's health care plan. Faulkner & Gray's Medicine & Health 46(7): Suppl 6 P.-Suppl 6 P.

Perspectives. The standard benefit package: trade-offs in the making. Faulkner & Gray's Medicine & Health 47(13): Suppl 4 P.-Suppl 4 P.

Perspectives. The state of Medicaid. Washington Report on Medicine & Health 38(12): Suppl 4p-Suppl 4p

Perspectives. The state of health planning. Washington Report on Medicine & Health 38(42): Suppl 6p-Suppl 6p

Perspectives. The uninsured: local efforts in state, federal, global contexts. Medicine & Health 54(8): Suppl 1-4

Perspectives. The wheels of policy grind slowly: top story of 1999 is Medicare Commission's decision to punt. Medicine & Health 54(1): Suppl 1-4

Perspectives. The year behind, the year ahead. Washington Report on Medicine & Health 40(1): Suppl 6 P.-Suppl 6 P.

Perspectives. The year in review, the year ahead. Mcgraw-Hill's Medicine & Health 41(1): Suppl 4 P.-Suppl 4 P.

Perspectives. The "catch 22" of caring for the retarded. Mcgraw-Hill's Washington Report on Medicine & Health 40(3): Suppl 4 P.-Suppl 4 P.

Perspectives. Thompson goes on road to seek ideas, support for demos. Medicine & Health 56(45): 7-8

Perspectives. Tight fiscal times force cooperation. Faulkner & Gray's Medicine & Health 46(20): Suppl 4 P.-Suppl 4 P.

Perspectives. Tim Westmoreland's slightly mad Medicaid mission. Interview by John Reichard. Medicine & Health 54(11): Suppl 1-4

Perspectives. Time is money: admin simplification on hold?. Medicine & Health 55(13): Suppl 1-2

Perspectives. Time to rethink? Providers ponder plan sponsorship anew. Medicine & Health 53(7): Suppl 1-4

Perspectives. To warn young people means to save the future. Soins; la Revue de Reference Infirmiere: 50-50

Perspectives. Tobacco deal: does the equation balance?. Medicine & Health 51(46): Suppl 1-4

Perspectives. Top stories of '96: HMO backlash, quest for quality. Faulkner & Gray's Medicine & Health 50(49): Suppl 1-4

Perspectives. Tough guy rules Medi-Cal program. Washington Report on Medicine & Health 37(4): Suppl 4p-Suppl 4p

Perspectives. Transplant technology outpaces policies. Washington Report on Medicine & Health 37(32): 4p-4p

Perspectives. Transplants raise fiscal and ethical questions. Mcgraw-Hill's Washington Report on Medicine & Health 40(18): Suppl 4 P.-Suppl 4 P.

Perspectives. Transplants: limited resources, unlimited need. Faulkner & Gray's Medicine & Health 45(47): Suppl 4 P.-Suppl 4 P.

Perspectives. Trauma care: preparing for the worst. Faulkner & Gray's Medicine & Health 47(35): Suppl 4 P.-Suppl 4 P.

Perspectives. Trauma centers on a collision course. Mcgraw-Hill's Medicine & Health 43(27): Suppl 4 P.-Suppl 4 P.

Perspectives. Try, try again: what's next for health care reform?. Faulkner & Gray's Medicine & Health 48(37): Suppl 1-6

Perspectives. Trying to rein in Medicare cost increases. Faulkner & Gray's Medicine & Health 46(10): Suppl 4 P.-Suppl 4 P.

Perspectives. Tuberculosis: the "white plague" rises. Faulkner & Gray's Medicine & Health 46(35): Suppl 4 P.-Suppl 4 P.

Perspectives. Twenty years of Maryland rate regulation. Faulkner & Gray's Medicine & Health 45(32): Suppl 4 P.-Suppl 4 P.

Perspectives. Twenty years of Medicaid. Washington Report on Medicine & Health 39(30): Suppl 4 P.-Suppl 4 P.

Perspectives. Twin studies analyze tactics for implementing guidelines. Faulkner & Gray's Medicine & Health 50(22): Suppl 1-4

Perspectives. Two reports help reset agenda for resumption of Medicare reform debate. Medicine & Health 54(6): Suppl 1-4

Perspectives. U.S. health report card: mixed performance. Faulkner & Gray's Medicine & Health 44(13): Suppl 4 P.-Suppl 4 P.

Perspectives. U.S. spends a lot on health but doesn't know what it buys. Medicine & Health 54(22): Suppl 1-4

Perspectives. UCDS: HCFA's ambitious automated review project. Faulkner & Gray's Medicine & Health 45(11): Suppl 4 P.-Suppl 4 P.

Perspectives. Uncompensated care: paying the price. Washington Report on Medicine & Health 38(37): Suppl 4p-Suppl 4p

Perspectives. Uninsured people get less care, worse care. Medicine & Health 56(19): 7-8

Perspectives. Uninsured take the spotlight. Mcgraw-Hill's Medicine & Health 43(6): Suppl 4 P.-Suppl 4 P.

Perspectives. Uninsured, unemployed under scrutiny. Washington Report on Medicine & Health 37(18): Suppl 4p-Suppl 4p

Perspectives. Union rules in limbo. Mcgraw-Hill's Medicine & Health 43(21): Suppl 4 P.-Suppl 4 P.

Perspectives. Unions push quality issues as workers and consumers. Faulkner & Gray's Medicine & Health 49(46): Suppl 1-4

Perspectives. Up from denial: more medical groups to seek to manage care. Faulkner & Gray's Medicine & Health 51(21): Suppl 1-4

Perspectives. Use of telemedicine for home care ripe for experiment. Medicine & Health 52(43): Suppl 1-4

Perspectives. User-friendly HMOs could stem tide of laws in West. Faulkner & Gray's Medicine & Health 50(45): Suppl 1-4

Perspectives. VA under fire for quality of care. Faulkner & Gray's Medicine & Health 45(22): Suppl 4 P.-Suppl 4 P.

Perspectives. Vaccines for Children program: bad policy or start-up glitches?. Faulkner & Gray's Medicine & Health 48(33): Suppl 1-4

Perspectives. Vertical integration: one response to DRGs. Washington Report on Medicine & Health 37(38): Suppl 4p-Suppl 4p

Perspectives. Veterans battle for medical care. Mcgraw-Hill's Medicine & Health 43(16): Suppl 4 P.-Suppl 4 P.

Perspectives. Veterans' health care: can it survive reform?. Faulkner & Gray's Medicine & Health 47(34): Suppl 4 P.-Suppl 4 P.

Perspectives. Viagra or bust: is pharmacy cost crisis unraveling HMO utilization strategy?. Medicine & Health 52(28): Suppl 1-4

Perspectives. Vouchers: can insurers outbid Medicare?. Washington Report on Medicine & Health 37(7): Suppl 4p-Suppl 4p

Perspectives. Wakened FTC worries providers. Mcgraw-Hill's Medicine & Health 42(14): Suppl 4 P.-Suppl 4 P.

Perspectives. Wall Street verbatim: wider networks need not drive new cost explosion. Medicine & Health 52(25): Suppl 1-4

Perspectives. Waning volunteerism is emergency for rural EMS. Medicine & Health 55(19): 7-8

Perspectives. Wanna lower health costs? Don't look to drug profits. Medicine & Health 55(15): Suppl 2 P.-Suppl 2 P.

Perspectives. WellPoint's new plans target uninsured, but scholars are skeptical. Medicine & Health 54(33): Suppl 1-4

Perspectives. What is lost if Congress overrides the states' negotiated tobacco settlement?. Medicine & Health 52(16): Suppl 1-4

Perspectives. What women want in medical research. Faulkner & Gray's Medicine & Health 44(37): Suppl 4 P.-Suppl 4 P.

Perspectives. What's ahead for capitation?. Mcgraw-Hill's Medicine & Health 40(42): Suppl 4 P.-Suppl 4 P.

Perspectives. What's next for Medi-Cal?. Washington Report on Medicine & Health 38(34): Suppl 4p-Suppl 4p

Perspectives. When a doctor has AIDS. Mcgraw-Hill's Medicine & Health 42(15): Suppl 4 P.-Suppl 4 P.

Perspectives. Where do we go from here with Medicare+Choice? The experts speak. Medicine & Health 54(47): Suppl 1-4

Perspectives. Where have all the doctors gone?. Mcgraw-Hill's Medicine & Health 42(35): Suppl 4 P.-Suppl 4 P.

Perspectives. Where we are, where we're going. Washington Report on Medicine & Health 38(1): Suppl 4p-Suppl 4p

Perspectives. White House health prescription. Washington Report on Medicine & Health 39(5): Suppl 4p-Suppl 4p

Perspectives. White House-CBO debate on cost of Medicare plan hinges on Medicaid, FFS reform issues. Medicine & Health 53(31): Suppl 1-4

Perspectives. Will HCFA remain a four-letter word?. Medicine & Health 55(20): 7-8

Perspectives. Will United help defuse backlash by scrapping authorization rules?. Medicine & Health 53(45): Suppl 1-4

Perspectives. Will an employer mandate sink small business?. Faulkner & Gray's Medicine & Health 47(15): Suppl 4 P.-Suppl 4 P.

Perspectives. Will for-profit trend hold up as HMO margins decline?. Faulkner & Gray's Medicine & Health 50(46): Suppl 1-4

Perspectives. Will genome science shift clinical, insurance paradigms?. Medicine & Health 54(37): Suppl 1-4

Perspectives. Will warring ballot measures in Arizona doom expanding health care for the poor?. Medicine & Health 54(41): Suppl 1-4

Perspectives. Will we try to manage care again? This time, for drugs?. Medicine & Health 54(25): Suppl 1-4

Perspectives. With regulations still unclear, PSOs prepare for Medicare. Faulkner & Gray's Medicine & Health 51(34): Suppl 1-4

Perspectives. Withholding treatment--who should decide?. Washington Report on Medicine & Health 38(38): Suppl 4p-Suppl 4p

Perspectives. Women's health: pursuing quality and equality in a changing health system. Medicine & Health 53(28): Suppl 1-4

Perspectives. Work environment a top issue in nurse retention. Medicine & Health 55(31): 7-8

Perspectives. Workers' comp: a complex adaptation for managed care. Faulkner & Gray's Medicine & Health 51(17): Suppl 1-4

Perspectives. Year 2000 objectives: altering the medical model. Medicine & Health 43(42): Suppl 4 P.-Suppl 4 P.

Perspectives. Year in review: ghost of reform returns to haunt GOP. Faulkner & Gray's Medicine & Health 50(1): Suppl 1-3

Perspectives. "Carving in" is the cutting edge of managed Medicaid mental health care. Medicine & Health 52(23): Suppl 1-4

Perspectives. "Fix it or forget it": the JCAHO in crisis. Faulkner & Gray's Medicine & Health 49(4): Suppl 1-4

Perspectives. "Other" Washington launches major health reform. Faulkner & Gray's Medicine & Health 47(21): Suppl 4 P.-Suppl 4 P.

Perspectives: A Practical Approach to the Dietary Treatment of Hypertriglyceridemia. Preventive Cardiology 4(4): 183-185

Perspectives: Antarctic biogeochemistry. Icy life on a hidden lake. Science 286(5447): 2094-2095

Perspectives: Benefits of a new, nonsystemic lipid-lowering agent: the clinician's perspective. Preventive Cardiology 4(1): 38-39

Perspectives: Benefits of reducing low-density lipoprotein cholesterol concentrations to <100 mg/dL. Preventive Cardiology 3(3): 136-139

Perspectives: Chemotherapy of medulloblastoma. Medical and Pediatric Oncology 33(2): 116-119

Perspectives: Evaluating the need and potential benefits of testing for plasma homocyst(e)ine, an independent risk factor for atherosclerotic disease. Preventive Cardiology 3(2): 93-96

Perspectives: NCEP III-A Call to Arms!. Preventive Cardiology 4(3): 132-134

Perspectives: Oral anticoagulant therapy: current issues. Preventive Cardiology 3(4): 178-182

Perspectives: Preventive cardiology in the new millennium: a virtual specialty?. Preventive Cardiology 3(1): 40-41

Perspectives: The NCEP ATP III guidelines-friend or foe? National Cholesterol Education Program. Preventive Cardiology 5(3): 152-155

Perspectives: The significance of measuring non-HDL-cholesterol. Preventive Cardiology 5(3): 156-159

Perspectives: behavior. Measuring beelines to food. Science 287(5454): 817-819

Perspectives: biomedicine. The benefits of recycling. Science 285(5432): 1363-1364

Perspectives: biosynthetic pathways. Biosynthesis meets bioinformatics. Science 287(5454): 818-819

Perspectives: cell biology. All creatures great and small. Science 285(5436): 2082-2083

Perspectives: cell cycle. The difficulty in separating sisters. Science 285(5426): 344-345

Perspectives: cognition. An innate basis for language?. Science 286(5448): 2283-2284

Perspectives: does amiodarone increase non-sudden deaths? If so, why?. Journal of Interventional Cardiac Electrophysiology 4(4): 569-574

Perspectives: drug delivery. Regulating export of ER cargo. Science 287(5454): 816-817

Perspectives: earth science and evolution. Genomics and the geosciences. Science 287(5453): 605-606

Perspectives: epidemiology. Simple rules with complex dynamics. Science 287(5453): 601-602

Perspectives: evolution. Is bigger better in cricket?. Science 287(5455): 985-986

Perspectives: evolutionary biology. A powerhouse divided. Science 287(5456): 1219-1219

Perspectives: evolutionary biology. Limbless tetrapods and snakes with legs. Science 287(5460): 1939-1941

Perspectives: evolutionary biology. Sex and death. Science 286(5449): 2458-2459

Perspectives: evolutionary biology. The evolutionary synthesis. Science 286(5444): 1490-1490

Perspectives: hospice benefit set to begin. Washington Report on Medicine & Health 37(34): Suppl 4p-Suppl 4p

Perspectives: how to stay on top of your career. Interview by Sue Telingator. Journal of Ahima 68(10): 70-72

Perspectives: immunology. Regulating the regulator. Science 285(5432): 1367-1367

Perspectives: microbiology. Mice are not furry petri dishes. Science 287(5457): 1409-1410

Perspectives: molecular medicine. "Sickle cell anemia, a molecular disease". Science 286(5444): 1488-1490

Perspectives: neurobiology. Cranking it up a notch. Science 286(5440): 689-690

Perspectives: neurobiology. Diversity in inhibition. Science 287(5451): 244-246

Perspectives: neurobiology. PrP's double causes trouble. Science 286(5441): 914-915

Perspectives: neurobiology. Regeneration in the Nogo zone. Science 287(5454): 813-814

Perspectives: neurobiology. The CRYs fo flies and mice. Science 286(5449): 2460-2461

Perspectives: neuroscience. Is art lawful?. Science 285(5428): 673-674

Perspectives: neuroscience. Remembrance of things past. Science 285(5433): 1503-1504

Perspectives: neuroscience. Strengthening visual connections. Science 287(5460): 1943-1944

Perspectives: on being a visiting scientist. Journal of Laboratory and Clinical Medicine 139(4): 192-193

Perspectives: on the accuracy of prophecies. Radiology 204(2): 32a-33a

Perspectives: paleoecology. The refugial debate. Science 287(5457): 1406-1407

Perspectives: parenting to the adolescent today. Soins. Psychiatrie: 40-40

Perspectives: plant biology. No stigma attached to male rejection. Science 286(5445): 1690-1691

Perspectives: plant biology. Some like it hot. Science 287(5452): 435, 437-435, 437

Perspectives: plant biology. The green revolution strikes gold. Science 287(5451): 241-243

Perspectives: protein structure. Class-conscious TCR?. Science 286(5446): 1867-1868

Perspectives: protein synthesis. All you need is RNA. Science 281(5377): 658-659

Perspectives: protein synthesis. Unraveling the riddle of ProCys tRNA synthetase. Science 287(5452): 440-441

Perspectives: quality assurance and risk management. Hospital Peer Review 6(3): 28-29

Perspectives: respiratory therapy services. Hospital Peer Review 5(12): 145-147

Perspectives: signal transduction. Cell survival demands some Rsk. Science 286(5443): 1309-1310

Perspectives: signal transduction. Inositol phosphates in the nucleus. Science 287(5460): 1937-1939

Perspectives: signal transduction. Proteins in motion. Science 285(5434): 1682-1683

Perspectives: signal transduction. Signals to move cells. Science 287(5455): 982-3, 985

Perspectives: some roles of mechanical usage, muscle strength, and the mechanostat in skeletal physiology, disease, and research. Calcified Tissue International 62(1): 1-7

Perspectives: some thoughts on the Adult Treatment Panel III report. Preventive Cardiology 5(2): 87-9, 93

Perspectives: structural biology. SRP--where the RNA and membrane worlds meet. Science 287(5456): 1212-1213

Perspectives: three domains in diagnostic radiology. Korean Journal of Radiology 1(1): 3-4

Perspectives: transcription. A tail of histone acetylation and DNA recombination. Science 287(5452): 438-440

Perspectivism, constructivism, and empathy in psychoanalysis: Nietzsche and Kohut. Journal of the American Academy of Psychoanalysis 25(3): 373-398

Perspicacity and the physician. Southern Medical Journal 87(10): 1054-1055

Perstannylated Ammonium and Phosphonium Ions: Organometallic Onium Ions That Are also Base-Stabilized Stannylium Ions This work was supported by the Deutsche Forschungsgemeinschaft, the Ministerium für Schule, Weiterbildung und Forschung des Landes Nordrhein-Westfalen and by the Fonds der Chemischen Industrie. Angewandte Chemie 39(20): 3684-3686

Persuade the HMO that a contract change you propose is also in the plan's interest. Managed Care 8(3): 58, 61-58, 61

Persuading old-school managers to be more democratic. American Journal of Hospital Pharmacy 50(11): 2302-2303

Persuading people to care. Modern Healthcare 18(49): 74-74

Persuading the persuadable: evaluating compulsory treatment in England using Supervised Discharge Orders. Social Psychiatry and Psychiatric Epidemiology 36(5): 260-266

Persuading young pharmacists to choose a hospital career. Health Service Journal 97(5058): 792-792

Persuading your audience: rhetoric revisited. Journal of Biocommunication 26(2): 14-16

Persuading youths that hops ain't hip. JAMA 280(6): 499-500

Persuasion and change. Health Progress 69(9): 57-59

Persuasion and economic efficiency. The cost-benefit analysis of banning abortion. Economics and Philosophy 9(2): 229-252

Persuasion and influence (continuing education credit). Nursing Standard 1987) 8(26): 47-52; Quiz 53-4

Persuasion and population control in India. Indian Psychological Review 18(1-4): 97-108

Persuasion as a strategy for managing up. American Journal of Health-System Pharmacy 58 Suppl 1: S4-S6

Persuasion as respect for persons: an alternative view of autonomy and of the limits of discourse. Journal of Medicine and Philosophy 26(1): 13-33

Persuasion for the purpose of cancer risk reduction: a discussion. Journal of the National Cancer Institute. Monographs: 119-122

Persuasion strategies for physician executives: Part I--Influencing superiors. Physician Executive 16(6): 9-13

Persuasion strategies for physician executives: Part II. Influencing subordinates. Physician Executive 17(1): 31-35

Persuasion, catharsis, aggression. Harvard Mental Health Letter 17(1): 6-7

Persuasive communication about AIDS prevention: need for cognition determines the impact of message format. Aids Education and Prevention 11(2): 150-162

Persuasive communication: marketing health promotion. Nursing Outlook 45(4): 173-177

Persuasive communities: a longitudinal analysis of references in the Philosophical Transactions of the Royal Society, 1665-1990. Social Studies of Science 24(2): 279-310

Persuasive conversations between friends about health and safety precautions. Health Education Quarterly 20(3): 347-360

Persuasive messages. Development of persuasive messages may help increase mothers' compliance of their children's immunization schedule. Marketing Health Services 18(4): 32-43

Persulfoxide: key intermediate in reactions of singlet oxygen with sulfides. Accounts of Chemical Research 34(11): 875-884

Pert analysis of endogenous retroviruses induced from K-BALB mouse cells treated with 5-iododeoxyuridine: a potential strategy for detection of inducible retroviruses from vaccine cell substrates. Developments in Biologicals 106: 387-92; Discussion 392-3

Pertechnetate activity in the gastric fundus and a small left kidney simulating an enlarged hydronephrotic kidney. Clinical Nuclear Medicine 25(11): 940-942

Perth and UK labs combine for PETS . Australian Veterinary Journal 78(12): 817-817

Perth-Western Australia, 28-31 October 1993. Report on the 18th Australian & New Zealand scientific meeting on intensive care. Australian Critical Care 6(4): 22-23

Perthes disease affecting three female first-degree relatives. Journal of Pediatric Orthopedics. Part B 7(3): 230-231

Perthes disease--results of a containment-oriented therapy concept. Zeitschrift für Orthopadie und Ihre Grenzgebiete 135(3): 242-251

Perthes lesion (a variant of the Bankart lesion): MR imaging and MR arthrographic findings with surgical correlation. Ajr. American Journal of Roentgenology 178(1): 233-237

Perthes syndrome. The classical symptom triad as a rarity in trauma surgery practice. Der Unfallchirurg 104(2): 191-194

Perthes' disease after the age of twelve years. Role of the remaining growth. Journal of Bone and Joint Surgery. British Volume 81(4): 696-698

Perthes' disease after "irritable hip": delayed bone age shows the hip is a "marked man". Journal of Pediatric Orthopedics 16(1): 20-23

Perthes' disease and blood manganese levels. Archives of Disease in Childhood 82(5): 428-428

Perthes' disease and the relevance of thrombophilia. Journal of Bone and Joint Surgery. British Volume 81(4): 691-695

Perthes' disease in the adolescent. Journal of Bone and Joint Surgery. British Volume 83(5): 715-720

Perthes' disease or late avascular necrosis after developmental dislocation of the hip? 10 children followed for 6-35 years. Acta Orthopaedica Scandinavica 72(4): 331-334

Perthes' disease. A study of constitutional aspects in adulthood. Journal of Bone and Joint Surgery. British Volume 83(4): 569-571

Perthes-like changes in geleophysic dysplasia. Journal of Pediatric Orthopedics. Part B 11(2): 100-103

Pertinence of analysis requests in primary care. Atencion Primaria 18(2): 87-89

Pertinence of kappa and lambda recombinant antibodies directed against thyroid peroxidase in thyroid autoimmune disease. Human Antibodies 10(3-4): 109-118

Pertinence of qualitative research: comparative approach in qualitative and quantitative research. Recherche en Soins Infirmiers: 13-22

Pertinence of the addiction concept in eating behavior disorders. Annales de Medecine Interne 151 Suppl B: B53-B60

Pertinent considerations in preterm infant management. Malaysian Journal of Reproductive Health 2(1): 51-82

Pertinent information on personal protective gear. Journal of Air Medical Transport 9(2): 18-20

Pertinent points. Journal of Sex & Marital Therapy 27(2): 117-119

Pertinent psychological issues in the immediate management of a weapons of mass destruction event. Military Medicine 166(12 Suppl): 59-60

Pertrochanteric femoral fracture in elderly patients--injury pattern and management with gamma nailing. Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 113: 996-998

Pertrochanteric fractures of the femur in patient with thrombophlebic crural ulcerations of the legs in the course of 50 years. Polski Merkuriusz Lekarski 8(44): 102-104

Pertrochanteric fractures: is there an advantage to an intramedullary nail?: a randomized, prospective study of 206 patients comparing the dynamic hip screw and proximal femoral nail. Journal of Orthopaedic Trauma 16(6): 386-393

Pertrochanteric pseudarthrosis. Implant failure - technical error - destiny?. Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 70(11): 1209-1215

Pertubation of beta1 integrin function using anti-sense or function-blocking antibodies on corneal cells grown on fibronectin and tenascin. Cell Biology International 26(2): 131-144

Pertubation with lignocaine--a possible new treatment for women with endometriosis and impaired fertility. Upsala Journal of Medical Sciences 106(1): 51-57

Perturbation Theory for Classical Solids. Physical Review Letters 77(11): 2249-2252

Perturbation analysis of a parametrically changed sine-Gordon equation. Physical Review. B, Condensed Matter 36(1): 217-225

Perturbation analysis of the primary instability in Taylor-Couette flow subjected to a Coriolis force. Physical Review. A, Atomic, Molecular, and Optical Physics 44(6): 3653-3663

Perturbation analysis of weakly discrete kinks. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 54(3): 2912-2916

Perturbation and proinflammatory type activation of V delta 1(+) gamma delta T cells in African children with Plasmodium falciparum malaria. Infection and Immunity 69(5): 3190-3196

Perturbation approach for the Kondo Hamiltonian. Physical Review. B, Condensed Matter 44(2): 721-726

Perturbation approach to the reflection and transmission of light. Physical Review. B, Condensed Matter 51(19): 13079-13083

Perturbation approximations for scattering amplitudes in ion-atom collisions. Physical Review. A, General Physics 37(7): 2365-2377

Perturbation calculation around the two-dimensional Ising model. Physical Review. B, Condensed Matter 37(16): 9889-9892

Perturbation calculations for infrared-divergent problems. Physical Review. D, Particles and Fields 32(8): 2223-2228

Perturbation corrections for flat and thimble-type cylindrical standard ionization chambers for 60Co gamma rays: Monte Carlo calculations. Physics in Medicine and Biology 43(10): 2721-2727

Perturbation dynamics for membranes and strings governed by the Dirac-Goto-Nambu action in curved space. Physical Review. D, Particles and Fields 48(10): 4835-4838

Perturbation effects in dosimetry: Part I. Kilovoltage x-rays and electrons. Physics in Medicine and Biology 41(9): 1531-1580

Perturbation effects on lifetimes of d 3 Pi u states in H2 and D2. Physical Review. A, Atomic, Molecular, and Optical Physics 48(6): 4771-4774

Perturbation expansion for particle distributions in hadron storage rings. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 47(6): 4405-4411

Perturbation expansion in phase-ordering kinetics. II. N-vector model. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 61(2): 1088-1101

Perturbation expansion of closed-time-path Green's functions. Physical Review. A, Atomic, Molecular, and Optical Physics 41(1): 53-59

Perturbation expansion of variational principles at arbitrary order. Physical Review. A, Atomic, Molecular, and Optical Physics 52(2): 1086-1095

Perturbation expansions of the response function and the asymptotic regime. Physical Review. B, Condensed Matter 43(13): 10070-10085

Perturbation formalism of an exact representation for the t-J model. Physical Review. B, Condensed Matter 53(3): 1171-1179

Perturbation growth and cosmic microwave background anisotropies in the stringlike matter-dominated universe. Physical Review. D, Particles and Fields 53(12): 7362-7364

Perturbation of C6 glial cells by acetate leads to modulation of [125I]IGF-II binding to the IGF-II/M6P receptor: implications for ligand internalization studies. Biochimica et Biophysica Acta 1223(2): 179-184

Perturbation of CD4+ and CD8+ T-cell repertoires during progression to AIDS and regulation of the CD4+ repertoire during antiviral therapy. Nature Medicine 4(2): 215-221

Perturbation of EGF-induced MAP kinase activation by TGF-beta 1. Brazilian Journal of Medical and Biological Research 32(7): 821-825

Perturbation of RET signaling in the embryonic kidney. Developmental Genetics 24(3-4): 263-272

Perturbation of Trp 138 in T4 lysozyme by mutations at Gln 105 used to correlate changes in structure, stability, solvation, and spectroscopic properties. Proteins 15(4): 401-412

Perturbation of a Cartilage Autocrine/Paracrine Basic Fibroblast Growth Factor Metabolic Regulatory Network by Osteoarthritic Synovial Tissue. American Journal of Therapeutics 3(1): 52-62

Perturbation of a prehension movement in Parkinson's disease. Movement Disorders 9(4): 415-425

Perturbation of gamma -ray angular correlation by an Ornstein-Ulhenbeck process. Physical Review. B, Condensed Matter 45(9): 4745-4751

Perturbation of higher-genus spatial surfaces in (2+1)-dimensional gravity. Physical Review. D, Particles and Fields 46(2): 572-577

Perturbation of higher-genus surfaces in (2+1)-dimensional gravity with a cosmological constant. Physical Review. D, Particles and Fields 47(4): 1706-1708

Perturbation of human skin due to application of high voltage. Bioelectrochemistry 51(1): 41-51

Perturbation of membrane microdomains reduces mitogenic signaling and increases susceptibility to apoptosis after T cell receptor stimulation. Cell Death and Differentiation 7(5): 413-424

Perturbation of the Electronic Structure of a Copper(II) ion by a Cu(I)Cl Moiety in a Class I Mixed Valence Copper Complex, Cu(II)(Me(5)dien)Cl(2)(Cu(I)Cl). Inorganic Chemistry 35(11): 3404-3408

Perturbation of the expression of the catalytic subunit C alpha of cyclic AMP-dependent protein kinase inhibits TCR-triggered secretion of IL-2 by T helper hybridoma cells. Journal of Immunology 158(1): 171-179

Perturbation of the mitosis/apoptosis balance: a fundamental mechanism in toxicology. Fundamental and Applied Toxicology 38(2): 107-115

Perturbation of tunneling processes by mechanical degrees of freedom in mesoscopic junctions. Physical Review. B, Condensed Matter 52(17): 12911-12920

Perturbation spectra from intermediate inflation. Physical Review. D, Particles and Fields 47(12): R5219-R5223

Perturbation spectrum of an expanding fluid with negligible initial power on small scales. Physical Review. D, Particles and Fields 54(8): 4744-4749

Perturbation study of shading in pictures. Perception 25(9): 1009-1026

Perturbation study on the spin and charge susceptibilities of the two-dimensional Hubbard model. Physical Review. B, Condensed Matter 54(8): 5381-5388

Perturbation theories of a discrete, integrable nonlinear Schrödinger equation. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 53(4): 4131-4136

Perturbation theory and the Aharonov-Bohm effect. Physical Review. D, Particles and Fields 52(4): 2466-2470

Perturbation theory applied to sound propagation in flowing media confined by a cylindrical waveguide. Journal of the Acoustical Society of America 109(1): 102-107

Perturbation theory applied to the freezing of classical systems. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 49(3): 2161-2166

Perturbation theory for Floquet eigenvalues in a zero-range potential. Physical Review. A, Atomic, Molecular, and Optical Physics 42(1): 452-458

Perturbation theory for Maxwell's equations with shifting material boundaries. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics 65(6 Pt 2): 066611-066611

Perturbation theory for an anharmonic oscillator. Physical Review. D, Particles and Fields 33(10): 3145-3146

Perturbation theory for coupled nonlinear Schrödinger equations. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 54(5): 5743-5751

Perturbation theory for diffuse light transport in complex biological tissues. Journal of the Optical Society of America. A, Optics, Image Science, and Vision 14(1): 255-261

Perturbation theory for domain walls in the parametric Ginzburg-Landau equation. Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics 64(5 Pt 2): 056618-056618

Perturbation theory for light diffraction with surface-polariton resonances on a bigrating. Physical Review. B, Condensed Matter 35(6): 2647-2659

Perturbation theory for solitons in optical fibers. Physical Review. A, Atomic, Molecular, and Optical Physics 42(9): 5689-5694

Perturbation theory for strongly interacting atomic systems. Physical Review. A, Atomic, Molecular, and Optical Physics 41(1): 207-219

Perturbation theory for the electrical conductivity of quasiperiodic lattices. Physical Review. B, Condensed Matter 37(12): 7091-7093

Perturbation theory for the formation energy of solitons and polarons in mixed-valence linear-chain complexes. Physical Review. B, Condensed Matter 44(24): 13260-13269

Perturbation theory for the free energy of classical two-dimensional solids with repulsive inverse-power interactions. Physical Review. B, Condensed Matter 49(22): 16028-16030

Perturbation theory for the kink of the sine-gordon equation. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 62(6 Pt B): 8842-8845

Perturbation theory for the triple-well anharmonic oscillator. Physical Review. A, Atomic, Molecular, and Optical Physics 41(3): 1218-1224

Perturbation theory for the two-dimensional polaron in a magnetic field. Physical Review. B, Condensed Matter 33(2): 799-806

Perturbation theory in multireference spaces. Physical Review. A, Atomic, Molecular, and Optical Physics 46(1): 95-104

Perturbation theory in the exact linearized kinetic equation for a plasma. Physical Review. E, Statistical Physics, Plasmas, Fluids, and Related Interdisciplinary Topics 47(6): 4619-4622

Perturbation theory in two-dimensional open string field theory. Physical Review. D, Particles and Fields 47(12): 5460-5469

Perturbation theory of a classical one-component plasma. Physical Review. A, General Physics 38(11): 5714-5726

Perturbation theory of diffuse RHEED applied to rough surfaces: Comparison with supercell calculations. Physical Review. B, Condensed Matter 54(3): 2121-2137

Perturbation theory of impurity diffusion. Physical Review. B, Condensed Matter 36(1): 289-310

Perturbation theory of low-dimensional quantum liquids. I. The pseudoparticle-operator basis. Physical Review. B, Condensed Matter 50(6): 3667-3682

Perturbation theory of low-dimensional quantum liquids. II. Operator description of Virasoro algebras in integrable systems. Physical Review. B, Condensed Matter 50(6): 3683-3695

Perturbation theory of single-soliton diffusion in one-dimensional nonlinear Klein-Gordon theories. Physical Review. A, General Physics 34(1): 510-517

Perturbation theory of superconducting micronetworks near the phase-transition boundary. Physical Review. B, Condensed Matter 38(13): 8767-8777

Perturbation theory of superconducting micronetworks: Second-order and self-induction effects. Physical Review. B, Condensed Matter 46(2): 1075-1087